Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	MYCBP2 RAP1GAP2 ARHGEF11 BCR ASAP1 AGFG1 PLCB1 KALRN SH2D3C ARFGEF1 ALS2 RGS12 ARFGAP2 KNDC1 AKAP13 ARHGEF26 FGD6	4.20e-05	507	217	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	MYCBP2 RAP1GAP2 ARHGEF11 BCR ASAP1 AGFG1 PLCB1 KALRN SH2D3C ARFGEF1 ALS2 RGS12 ARFGAP2 KNDC1 AKAP13 ARHGEF26 FGD6	4.20e-05	507	217	17	GO:0030695
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	MYCBP2 ARHGEF11 BCR KALRN SH2D3C ARFGEF1 ALS2 KNDC1 AKAP13 ARHGEF26 FGD6	4.73e-05	231	217	11	GO:0005085
GeneOntologyMolecularFunction	histone H3K9 monomethyltransferase activity	ASH1L SETD5 PRDM16	6.81e-05	8	217	3	GO:0140948
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	ASH1L KMT2C KMT2D SETD5 PRDM16	1.11e-04	44	217	5	GO:0140938
GeneOntologyMolecularFunction	histone H3K9me2 methyltransferase activity	ASH1L SETD5 PRDM16	1.44e-04	10	217	3	GO:0140947
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	ASH1L SETD5 PRDM16	3.34e-04	13	217	3	GO:0046974
GeneOntologyMolecularFunction	enzyme regulator activity	IRGM MYCBP2 BCAS3 RAP1GAP2 SOCS6 KLF4 ARHGEF11 BCR ASAP1 TAOK2 FZR1 AGFG1 PLCB1 KALRN SH2D3C ARFGEF1 NLRP1 RICTOR ALS2 CIT RGS12 FAF1 PPP1R1A ARFGAP2 KNDC1 AKAP13 MARK2 CABIN1 ARHGEF26 FGD6	3.46e-04	1418	217	30	GO:0030234
GeneOntologyMolecularFunction	transcription coregulator activity	RAD54L2 BCL9 ARID1A KMT2C TCF20 MED1 YEATS2 NCOR2 KMT2D SETD5 GSDMD NCOA7 MYOCD YY1AP1 PRDM16 PBXIP1	4.50e-04	562	217	16	GO:0003712
GeneOntologyMolecularFunction	transcription coactivator activity	BCL9 ARID1A KMT2C TCF20 MED1 KMT2D GSDMD NCOA7 MYOCD PRDM16 PBXIP1	5.03e-04	303	217	11	GO:0003713
GeneOntologyMolecularFunction	protein serine kinase activity	MAST2 BCR TAOK2 MAST4 RPS6KL1 CDC42BPG KALRN MINK1 CIT CDK13 MARK2 ALPK2	6.49e-04	363	217	12	GO:0106310
GeneOntologyMolecularFunction	enzyme activator activity	IRGM BCAS3 RAP1GAP2 ARHGEF11 BCR ASAP1 TAOK2 FZR1 AGFG1 PLCB1 ARFGEF1 NLRP1 RICTOR ALS2 RGS12 ARFGAP2 MARK2	8.62e-04	656	217	17	GO:0008047
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	ASH1L KMT2C KMT2D SETD5 PRDM16	8.65e-04	68	217	5	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	ASH1L KMT2C KMT2D SETD5 PRDM16	9.25e-04	69	217	5	GO:0016278
GeneOntologyMolecularFunction	GTPase activator activity	RAP1GAP2 ARHGEF11 BCR ASAP1 AGFG1 PLCB1 ARFGEF1 ALS2 RGS12 ARFGAP2	9.91e-04	279	217	10	GO:0005096
GeneOntologyMolecularFunction	histone methyltransferase activity	ASH1L KMT2C KMT2D SETD5 PRDM16	1.05e-03	71	217	5	GO:0042054
GeneOntologyMolecularFunction	histone H3K36 trimethyltransferase activity	ASH1L SETD5	1.15e-03	5	217	2	GO:0140955
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	ASH1L KMT2C KMT2D	1.26e-03	20	217	3	GO:0042800
HumanPheno	Renal agenesis	EYA1 PIK3C2A KDM6A TBX1 KNL1 SALL4 CIT PALB2 ZIC2 KMT2D WDR11 SASS6	2.16e-05	209	70	12	HP:0000104
HumanPheno	Branchial sinus	EYA1 KDM6A KMT2D	2.44e-05	5	70	3	HP:0100272
HumanPheno	Vesicoureteral reflux	EYA1 KMT2C KDM6A BICC1 TBX1 KNL1 CLIP2 SALL4 CIT KMT2D SASS6 AFF4	3.77e-05	221	70	12	HP:0000076
HumanPheno	Unilateral renal agenesis	EYA1 KDM6A TBX1 KNL1 CIT PALB2 KMT2D SASS6	6.18e-05	101	70	8	HP:0000122
Domain	ZnF_C2HC	FAM90A14 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10	2.81e-06	55	212	7	SM00343
Domain	Znf_CCHC	FAM90A14 FAM90A1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10	2.81e-06	55	212	7	IPR001878
Domain	PH_dom-like	ARHGEF11 BCR ASAP1 SPTBN5 PLCB1 PLEKHA7 DOK1 CDC42BPG KALRN ALS2 CIT RGS12 AKAP13 FRMPD3 ARHGEF26 TNS1 FGD6	7.83e-06	426	212	17	IPR011993
Domain	NUT	NUTM2A NUTM1 NUTM2B	1.42e-05	5	212	3	IPR024310
Domain	NUT_N	NUTM2A NUTM1 NUTM2B	1.42e-05	5	212	3	IPR024309
Domain	NUT	NUTM2A NUTM1 NUTM2B	1.42e-05	5	212	3	PF12881
Domain	RhoGEF	ARHGEF11 BCR KALRN ALS2 AKAP13 ARHGEF26 FGD6	1.44e-05	70	212	7	PF00621
Domain	DH_2	ARHGEF11 BCR KALRN ALS2 AKAP13 ARHGEF26 FGD6	1.44e-05	70	212	7	PS50010
Domain	-	ARHGEF11 BCR KALRN ALS2 AKAP13 ARHGEF26 FGD6	1.58e-05	71	212	7	1.20.900.10
Domain	DH-domain	ARHGEF11 BCR KALRN ALS2 AKAP13 ARHGEF26 FGD6	1.58e-05	71	212	7	IPR000219
Domain	PH	ARHGEF11 BCR ASAP1 SPTBN5 PLEKHA7 DOK1 CDC42BPG KALRN ALS2 CIT AKAP13 ARHGEF26 FGD6	1.84e-05	278	212	13	SM00233
Domain	PH_DOMAIN	ARHGEF11 BCR ASAP1 SPTBN5 PLEKHA7 DOK1 CDC42BPG KALRN ALS2 CIT AKAP13 ARHGEF26 FGD6	1.91e-05	279	212	13	PS50003
Domain	PH_domain	ARHGEF11 BCR ASAP1 SPTBN5 PLEKHA7 DOK1 CDC42BPG KALRN ALS2 CIT AKAP13 ARHGEF26 FGD6	1.98e-05	280	212	13	IPR001849
Domain	-	ARHGEF11 BCR ASAP1 SPTBN5 PLEKHA7 DOK1 CDC42BPG KALRN ALS2 CIT RGS12 AKAP13 ARHGEF26 TNS1 FGD6	4.27e-05	391	212	15	2.30.29.30
Domain	PH	BCR ASAP1 SPTBN5 PLEKHA7 DOK1 CDC42BPG KALRN CIT AKAP13 ARHGEF26 FGD6	6.41e-05	229	212	11	PF00169
Domain	DH_1	ARHGEF11 BCR KALRN ALS2 AKAP13 ARHGEF26	7.90e-05	63	212	6	PS00741
Domain	EPHD	KMT2C TCF20 MLLT10 KMT2D	1.01e-04	22	212	4	PS51805
Domain	RhoGEF	ARHGEF11 BCR KALRN AKAP13 ARHGEF26 FGD6	1.21e-04	68	212	6	SM00325
Domain	SET	ASH1L KMT2C KMT2D SETD5 PRDM16	1.69e-04	46	212	5	SM00317
Domain	AT_hook	ASH1L ZBTB24 PRR12 KMT2C	2.31e-04	27	212	4	SM00384
Domain	AT_hook_DNA-bd_motif	ASH1L ZBTB24 PRR12 KMT2C	2.31e-04	27	212	4	IPR017956
Domain	SET_dom	ASH1L KMT2C KMT2D SETD5 PRDM16	2.51e-04	50	212	5	IPR001214
Domain	SET	ASH1L KMT2C KMT2D SETD5 PRDM16	2.51e-04	50	212	5	PS50280
Domain	DUF4599	SPATA31E1 SPATA31C1 SPATA31C2	2.94e-04	12	212	3	PF15371
Domain	DUF4599	SPATA31E1 SPATA31C1 SPATA31C2	2.94e-04	12	212	3	IPR027970
Domain	PL48	RIPOR3 RIPOR1	3.82e-04	3	212	2	PF15903
Domain	FAM65_N	RIPOR3 RIPOR1	3.82e-04	3	212	2	IPR031780
Domain	FAM65	RIPOR3 RIPOR1	3.82e-04	3	212	2	IPR026136
Domain	CNH	CDC42BPG MINK1 CIT	4.79e-04	14	212	3	SM00036
Domain	PHD	ASH1L KMT2C TCF20 MLLT10 TRIM33 KMT2D	5.29e-04	89	212	6	SM00249
Domain	CNH	CDC42BPG MINK1 CIT	5.93e-04	15	212	3	PF00780
Domain	CNH	CDC42BPG MINK1 CIT	5.93e-04	15	212	3	PS50219
Domain	CNH_dom	CDC42BPG MINK1 CIT	5.93e-04	15	212	3	IPR001180
Domain	Znf_PHD	ASH1L KMT2C TCF20 MLLT10 TRIM33 KMT2D	5.96e-04	91	212	6	IPR001965
Domain	Post-SET_dom	ASH1L KMT2C KMT2D	7.24e-04	16	212	3	IPR003616
Domain	PostSET	ASH1L KMT2C KMT2D	7.24e-04	16	212	3	SM00508
Domain	AT_hook	ZBTB24 PRR12 KMT2C	7.24e-04	16	212	3	PF02178
Domain	POST_SET	ASH1L KMT2C KMT2D	7.24e-04	16	212	3	PS50868
Domain	ZF_PHD_2	ASH1L KMT2C TCF20 MLLT10 TRIM33 KMT2D	7.48e-04	95	212	6	PS50016
Domain	DUF1908	MAST2 MAST4	7.58e-04	4	212	2	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST2 MAST4	7.58e-04	4	212	2	IPR015022
Domain	MAST_pre-PK_dom	MAST2 MAST4	7.58e-04	4	212	2	IPR023142
Domain	-	MAST2 MAST4	7.58e-04	4	212	2	1.20.1480.20
Domain	ZF_PHD_1	ASH1L KMT2C TCF20 MLLT10 TRIM33 KMT2D	7.91e-04	96	212	6	PS01359
Domain	C1	KMT2C PDZD8 CDC42BPG CIT AKAP13	8.54e-04	65	212	5	SM00109
Domain	PE/DAG-bd	KMT2C PDZD8 CDC42BPG CIT AKAP13	9.16e-04	66	212	5	IPR002219
Domain	PDZ	ARHGEF11 MAST2 MAST4 PDZD8 PARD3B RGS12 FRMPD3	1.15e-03	141	212	7	PF00595
Domain	SET	ASH1L KMT2C KMT2D SETD5	1.18e-03	41	212	4	PF00856
Domain	FYrich_C	KMT2C KMT2D	1.25e-03	5	212	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	1.25e-03	5	212	2	IPR003888
Domain	FYRC	KMT2C KMT2D	1.25e-03	5	212	2	SM00542
Domain	FYRN	KMT2C KMT2D	1.25e-03	5	212	2	SM00541
Domain	FYRN	KMT2C KMT2D	1.25e-03	5	212	2	PF05964
Domain	FYRC	KMT2C KMT2D	1.25e-03	5	212	2	PF05965
Domain	FYRC	KMT2C KMT2D	1.25e-03	5	212	2	PS51543
Domain	FYRN	KMT2C KMT2D	1.25e-03	5	212	2	PS51542
Domain	Znf_FYVE_PHD	ASH1L KMT2C TCF20 MLLT10 TRIM33 KMT2D FGD6	1.47e-03	147	212	7	IPR011011
Domain	PDZ	ARHGEF11 MAST2 MAST4 PDZD8 PARD3B RGS12 FRMPD3	1.52e-03	148	212	7	SM00228
Domain	PHD	ASH1L KMT2C MLLT10 TRIM33 KMT2D	1.63e-03	75	212	5	PF00628
Domain	-	ARHGEF11 MAST2 MAST4 PDZD8 PARD3B RGS12 FRMPD3	1.65e-03	150	212	7	2.30.42.10
Domain	PDZ	ARHGEF11 MAST2 MAST4 PDZD8 PARD3B RGS12 FRMPD3	1.71e-03	151	212	7	PS50106
Domain	PDZ	ARHGEF11 MAST2 MAST4 PDZD8 PARD3B RGS12 FRMPD3	1.78e-03	152	212	7	IPR001478
Domain	Znf_PHD-finger	ASH1L KMT2C MLLT10 TRIM33 KMT2D	2.05e-03	79	212	5	IPR019787
Pubmed	Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.	FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	2.04e-20	25	226	12	17684299
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPHK2 HIVEP2 ZNF585A MYCBP2 BCAS3 RAP1GAP2 BCL9 ARID1A KLF4 ARHGEF11 MAST2 BCR TAOK2 PCNX2 PRR12 KMT2C FZR1 CLN3 NAV2 NAV1 PDZD8 RIPOR1 MICAL3 DLX2 KALRN MLLT10 ADGRA2 CIT NHSL1 NCOR2 KMT2D ZNF592 SETD5 CDK13 AKAP13 CEP131 CABIN1 DHX34 PRDM16	6.52e-18	1105	226	39	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 SPAST AFTPH MYCBP2 BCAS3 MAST2 BCR CEP170 FAM117A MAST4 PIK3C2A AGFG1 NAV2 NAV1 PLEKHA7 BICC1 TCF20 MINK1 ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 RGS12 KIAA1671 NHSL1 ARFGAP2 NCOA7 AKAP13 CEP131 SSH2 MARK2 FGD6	3.87e-17	861	226	34	36931259
Pubmed	Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.	FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.17e-16	23	226	10	18602769
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP2 MYCBP2 BCAS3 ATXN7L1 MYT1 ASH1L ARID1A BCR TERF2IP PCNX2 CEP170 KMT2C NAV1 RIPOR1 RPRD2 MICAL3 DAGLA KDM6A RPS6KL1 CAP2 PRUNE2 CDC42BPG EP400P1 SOBP DTNA MINK1 PARD3B BCAR1 FAF1 KIAA1671 YEATS2 PACS1 NCOR2 WDR11 SETD5 CDK13 EEPD1 KNDC1 RBM5 AKAP13 ARHGEF26 AFF4	8.36e-16	1489	226	42	28611215
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	AFTPH MYCBP2 BCL7C TATDN2 BCL9 TERF2IP USP42 CLN3 ZNF644 RIPOR1 MICAL3 KDM6A CNOT3 SEC16B TCF20 MINK1 RICTOR MED1 PALB2 PITPNM1 TUBGCP6 YEATS2 PACS1 NCOR2 KMT2D ZNF592 CDK13 YY1AP1 MARK2	3.67e-14	774	226	29	15302935
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYC ZSWIM8 ATXN7L1 BCL7C ASH1L ARID1A MAST2 BCR GJD4 CEP170 ZNF469 ADGRL2 KNL1 USP36 EP400P1 FBF1 ZNF629 RICTOR ZIC2 ARG2 KIAA1671 TUBGCP6 TRIM33 YEATS2 NCOR2 ZNF592 SETD5 BICRAL DHX34 PRDM16 AFF4	1.11e-11	1116	226	31	31753913
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYCBP2 TSC1 EYA1 ARID1A ASAP1 TTC7B PTPRZ1 PYCR1 PDZD8 MICAL3 ADGRL2 PLEKHA7 KDM6A CAP2 KNL1 USP36 DTNA MINK1 RICTOR BCAR1 RBM20 KIAA1671 NHSL1 PACS1 NCOR2 KMT2D WDR11 CEP131 SSH2 TNS1	1.21e-11	1049	226	30	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYCBP2 TSC1 BCL9 ARHGEF11 BCR DNAJC6 TAOK2 CEP170 PLCB1 NAV1 UNC79 CAP2 TCF20 CLIP2 KALRN MINK1 CIT ZIC2 NCOR2 NCAN CEP131 SSH2 FRMPD3 CABIN1 ARHGEF26 TNS1 AFF4	2.17e-10	963	226	27	28671696
Pubmed	Human transcription factor protein interaction networks.	MYC ATXN7L1 RC3H1 BCL7C RAD54L2 BCL9 ARID1A KLF4 PRR12 KMT2C ZNF644 RPRD2 KDM6A CNOT3 TCF20 SOBP DTNA ZNF629 MLLT10 CIT RBM20 KIAA1671 TRIM33 YEATS2 NCOR2 KMT2D GTF3C2 ZNF592 YY1AP1 CEP131 CABIN1 PRDM16 SP7	2.80e-10	1429	226	33	35140242
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ZSWIM8 TSC1 RAD54L2 ARID1A BCR ZNF644 AGFG1 NAV1 CNOT3 KNL1 DTNA ZNF629 BCAR1 RBM20 KIAA1671 TRIM33 YEATS2 NCOR2 SASS6 YY1AP1 CEP131	3.55e-10	588	226	21	38580884
Pubmed	A human MAP kinase interactome.	MYC HIVEP2 RAP1GAP2 NCKAP5 ARHGEF11 ASAP1 KMT2C AGFG1 PLCB1 NAV2 NAV1 CAP2 TCF20 CLIP2 MUC12 AKAP13 YY1AP1 BICRAL TNS1	5.75e-10	486	226	19	20936779
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZSWIM8 ADAM19 HIVEP2 SPAST MYCBP2 ASH1L RAP1GAP2 NCKAP5 RAD54L2 ARID1A CCDC85A TERF2IP TTC7B PDZD8 KDM6A CNOT3 MTUS2 CAP2 CLIP2 KALRN CIT FAF1 ARG2 TRIM33 ZNF592 YY1AP1 CABIN1 NEUROD6 PBXIP1 AFF4	1.54e-09	1285	226	30	35914814
Pubmed	Interaction network of human early embryonic transcription factors.	HIVEP2 BCL7C RAD54L2 BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 SOBP KIAA1671 TRIM33 NCOR2 KMT2D PRDM16	1.56e-09	351	226	16	38297188
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RC3H1 ARMCX2 CCDC85A CEP170 PRR12 MICAL3 CNOT3 PRUNE2 SEC16B CLIP2 ZNF629 RICTOR WDR11 CDK13 EEPD1 SSH2 PRDM16 FGD6	4.82e-09	493	226	18	15368895
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ARID1A PRR12 KMT2C KDM6A TCF20 NLRP1 FAM90A1 RBM20 TRIM33 YEATS2 NCOR2 ARFGAP2 KMT2D YY1AP1 BICRAL PRDM16	9.29e-09	398	226	16	35016035
Pubmed	Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network.	FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A22 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10	1.17e-08	164	226	11	22967998
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPAST BCR TAOK2 KMT2C MAST4 PLCB1 NAV2 RPRD2 ADGRL2 DAGLA USP36 FBF1 ADGRA2 TUBGCP6 TRIM33 GTF3C2 ZNF592 DHX34	1.43e-08	529	226	18	14621295
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYCBP2 BCR PRR12 ZNF644 NAV1 KNL1 TCF20 RBM20 PALB2 KIAA1671 YEATS2 NCOR2 KMT2D GTF3C2 ZNF592 CEP131	1.84e-08	418	226	16	34709266
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	BCL7C BCL9 ARID1A KLF4 PRR12 RPRD2 KDM6A KNL1 TCF20 MED1 TRIM33 KMT2D AFF4	2.67e-08	268	226	13	33640491
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MYC AFTPH SPATA31E1 RAD54L2 BCL9 ASAP1 ZNF469 AGFG1 PLEKHA7 PRUNE2 BCAR1 MLLT10 KIAA1671 NCOR2 XIRP2 AKAP13	2.73e-08	430	226	16	35044719
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 ZBTB24 KMT2C PLCB1 NAV2 RPRD2 DAGLA PRUNE2 CLIP2 ALS2 ADGRA2 PRDM16	3.27e-08	225	226	12	12168954
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CEP170 PRR12 PIK3C2A NAV1 RPRD2 TRIM33 YEATS2 NCOR2 KMT2D ZNF592 CEP131	3.86e-08	184	226	11	32908313
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HIVEP2 TATDN2 MAST2 PIK3C2A ZNF644 NAV1 KNL1 SYBU ZIC2 WDR11 RBM5 AKAP13	4.58e-08	232	226	12	25515538
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RAD54L2 MAST2 BCR PRR12 MICAL3 CDC42BPG MINK1 ZNF629 RICTOR RBM20 PACS1 ARFGAP2 WDR11 CDK13 AKAP13 YY1AP1 MARK2 DHX34 PBXIP1	6.19e-08	650	226	19	38777146
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PDE1C BCAS3 TSC1 ARID1A ARHGEF11 BCR DNAJC6 ASAP1 CEP170 TTC7B PTPRZ1 NAV1 MICAL3 PLEKHA7 DAGLA MTUS2 CLIP2 KALRN MINK1 CIT PITPNM1 NHSL1 PACS1 NCAN KNDC1 SSH2 MARK2 TNS1 PBXIP1	6.45e-08	1431	226	29	37142655
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	BCL9 ARID1A PRR12 KDM6A TCF20 MED1 NCOR2 KMT2D	7.29e-08	83	226	8	28794006
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL7C EYA1 ARMCX2 ARID1A TERF2IP KMT2C USP42 UNC79 KDM6A PARD3B SALL4 TRIM33 KMT2D GTF3C2 ZNF592 CDK13	8.97e-08	469	226	16	27634302
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	AFTPH KLF4 ARHGEF11 TERF2IP TAOK2 PRR12 KMT2C PIK3C2A PLEKHA7 SPTY2D1 CNOT3 USP36 MINK1 RICTOR MED1 CIT SLC30A7 KIAA1671 TRIM33 GTF3C2 WDR11 ZNF592 SETD5 CDK13 RBM5 CEP131 MARK2 PBXIP1 AFF4	1.66e-07	1497	226	29	31527615
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TSC1 PLCB1 NAV2 NAV1 MICAL3 PLEKHA7 DTNA MINK1 USP43 ARFGEF1 RICTOR RGS12 PACS1 SIGLEC6 MARK2 ARHGEF26 FGD6	2.31e-07	569	226	17	30639242
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ATXN7L1 RAD54L2 TERF2IP ZNF644 RPRD2 SPTY2D1 USP36 TCF20 TRIM33 YEATS2 AFF4	2.59e-07	222	226	11	37071664
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MYC ARID1A KLF4 TERF2IP PRR12 KMT2C USP42 ZNF644 RPRD2 KDM6A SPTY2D1 USP36 TICRR TCF20 GPATCH1 ZNF629 MED1 PALB2 YEATS2 NCOR2 KMT2D GTF3C2 POLR3E CDK13 RBM5 CABIN1	3.85e-07	1294	226	26	30804502
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ATXN7L1 ASAP1 PRR12 KIAA1210 FZR1 ZNF644 NAV1 YEATS2	3.93e-07	103	226	8	10574462
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	ARID1A DNAJC6 TTC7B USP42 NAV1 DAGLA USP36 ARFGEF1 ELL2 CDK13	4.34e-07	186	226	10	33637726
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RAP1GAP2 TSC1 CSMD3 DNAJC6 ASAP1 ZNF644 NAV1 RIPOR1 MICAL3 TCF20 ALS2 YEATS2 SETD5 YY1AP1	5.29e-07	407	226	14	12693553
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SPAST MYCBP2 RAD54L2 BCL9 ARID1A CEP170 PRR12 KMT2C ZNF644 KDM6A KNL1 TCF20 ZNF629 MED1 CIT PALB2 TRIM33 YEATS2 NCOR2 KMT2D CDK13 RBM5 BICRAL	1.01e-06	1103	226	23	34189442
Pubmed	Cancer gene mutation frequencies for the U.S. population.	ARID1A KMT2C KMT2D	1.08e-06	4	226	3	34645806
Pubmed	Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.	ARID1A KDM6A KMT2D	1.08e-06	4	226	3	26138514
Pubmed	Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells.	MYC TSC1 RICTOR	1.08e-06	4	226	3	24282297
Pubmed	N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.	EMILIN2 KMT2C ZNF644 TCF20 SMARCAL1 TUBGCP6 ZNF592 SETD5 AKAP13 DHX34	1.76e-06	217	226	10	34048709
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	MYC RAD54L2 ARMCX2 ARID1A TERF2IP PRR12 RPRD2 KNL1 TCF20 MED1 PALB2 TRIM33 RBM5 CABIN1	1.87e-06	453	226	14	29656893
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	RC3H1 BCL9 ARID1A PRR12 KMT2C PIK3C2A BICC1 TCF20 RBM20 TRIM33 YEATS2 NCOR2 KMT2D MTX1	2.07e-06	457	226	14	32344865
Pubmed	Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity.	ASH1L SETD5 PRDM16	2.68e-06	5	226	3	22939622
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	RAD54L2 BCL9 ARHGEF11 PRR12 RPRD2 PLEKHA7 TCF20 NCOR2 MARK2	3.00e-06	180	226	9	35198878
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MYCBP2 BCAS3 DNAJC6 PIK3C2A PLCB1 MICAL3 CAP2 CLIP2 MINK1 CIT PITPNM1 MARK2	3.29e-06	347	226	12	17114649
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	TTC7B PLCB1 MICAL3 ADGRL2 PLEKHA7 DTNA MINK1 PARD3B RICTOR NHSL1 PACS1 EEPD1 MARK2	4.41e-06	421	226	13	36976175
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYCBP2 SOCS6 ARMCX2 MAST2 ASAP1 CEP170 PIK3C2A MYPN KALRN DTNA FAF1 XIRP2 ZNF592 RBM5	5.41e-06	497	226	14	23414517
Pubmed	A germline-specific class of small RNAs binds mammalian Piwi proteins.	KREMEN1 SPATA31E1 ASH1L EMILIN2 TATDN2 RPS6KL1 RGS12 KIAA1671 YEATS2 KNDC1 MARK2 MTX1 AFF4	9.01e-06	450	226	13	16751776
Pubmed	Maternal epigenetic factors in embryonic and postnatal development.	KDM6A MLLT10 PRDM16	9.30e-06	7	226	3	36906847
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	ARID1A KMT2C SALL4 MED1 TRIM33 YEATS2 KMT2D CABIN1	1.47e-05	167	226	8	20362541
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	ASH1L KMT2C KMT2D	1.48e-05	8	226	3	23130995
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ARID1A TAOK2 ZNF644 TCF20 SMARCAL1 GPATCH1 ARFGEF1 MED1 KMT2D YY1AP1 AFF4	1.62e-05	341	226	11	32971831
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SPAST MYCBP2 BCAS3 BCR ASAP1 TAOK2 CEP170 PLCB1 NAV1 CNOT3 KALRN DTNA MINK1 RICTOR CIT PITPNM1 NHSL1 ARFGAP2 KNDC1 CEP131 MTX1	1.96e-05	1139	226	21	36417873
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MYC HIVEP2 ASH1L ZBTB24 HOXA3 DLX2 CNOT3 TCF20 SALL4 MLLT10 MED1 ZIC2 NCOR2 POLR3E ZNF592 MYOCD PBXIP1 SP7	1.96e-05	877	226	18	20211142
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	BCL9 ARID1A CCDC85A PLCB1 PYCR1 KDM6A KNL1 TCF20 SMARCAL1 FBF1 MUC16 MED1 YEATS2 NCOR2 KMT2D	2.12e-05	638	226	15	31182584
Pubmed	Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.	MYC KLF4 KMT2D	2.21e-05	9	226	3	26691508
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	BCAS3 SOCS6 PCNX2 KMT2C TTC7B TCF20 KALRN SYBU XIRP2	2.39e-05	233	226	9	37704626
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	AFTPH TERF2IP MYPN NAV2 RPRD2 KALRN BCAR1 MED1 GTF3C2 CDK13 AKAP13 CEP131 MARK2	2.89e-05	503	226	13	16964243
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	MYC ARID1A RPRD2 TCF20 MED1 TRIM33 YEATS2	2.91e-05	134	226	7	25452129
Pubmed	Rebalancing gene haploinsufficiency in vivo by targeting chromatin.	KMT2C TBX1 CDC42BPG SALL4	3.15e-05	28	226	4	27256596
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	ARID1A KMT2C CNOT3 MED1 AFF4	4.17e-05	59	226	5	28813667
Pubmed	Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.	MYC KLF4	4.20e-05	2	226	2	23089465
Pubmed	The Guanine nucleotide exchange factor kalirin-7 is a novel synphilin-1 interacting protein and modifies synphilin-1 aggregate transport and formation.	KALRN SNCAIP	4.20e-05	2	226	2	23284848
Pubmed	Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression.	HOXA3 KDM6A	4.20e-05	2	226	2	36215227
Pubmed	Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells.	KLF4 MYOCD	4.20e-05	2	226	2	24060351
Pubmed	Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.	KDM6A KMT2D	4.20e-05	2	226	2	24739679
Pubmed	SMARCAL1 Negatively Regulates C-Myc Transcription By Altering The Conformation Of The Promoter Region.	MYC SMARCAL1	4.20e-05	2	226	2	26648259
Pubmed	Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.	KDM6A KMT2D	4.20e-05	2	226	2	31935506
Pubmed	Progressive kidney degeneration in mice lacking tensin.	BCAR1 TNS1	4.20e-05	2	226	2	9087448
Pubmed	Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.	KDM6A KMT2D	4.20e-05	2	226	2	32803813
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	4.20e-05	2	226	2	31924266
Pubmed	Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.	KDM6A KMT2D	4.20e-05	2	226	2	23184418
Pubmed	Identification of a large Myc-binding protein that contains RCC1-like repeats.	MYC MYCBP2	4.20e-05	2	226	2	9689053
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	4.20e-05	2	226	2	28967912
Pubmed	The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.	ELL2 AFF4	4.20e-05	2	226	2	21242887
Pubmed	Kabuki syndrome: clinical and molecular diagnosis in the first year of life.	KDM6A KMT2D	4.20e-05	2	226	2	25281733
Pubmed	Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.	KLF4 MYOCD	4.20e-05	2	226	2	25100730
Pubmed	Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation.	MYC NCOR2	4.20e-05	2	226	2	34864816
Pubmed	Histone Demethylase UTX is an Essential Factor for Zygotic Genome Activation and Regulates Zscan4 Expression in Mouse Embryos.	MYC KDM6A	4.20e-05	2	226	2	31595154
Pubmed	Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals.	KDM6A KMT2D	4.20e-05	2	226	2	29907798
Pubmed	Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia.	KDM6A KMT2D	4.20e-05	2	226	2	26049589
Pubmed	Putative digenic inheritance of heterozygous RP1L1 and C2orf71 null mutations in syndromic retinal dystrophy.	PCARE RP1L1	4.20e-05	2	226	2	27029556
Pubmed	Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome.	KDM6A KMT2D	4.20e-05	2	226	2	22840376
Pubmed	Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.	KDM6A KMT2D	4.20e-05	2	226	2	27302555
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	4.20e-05	2	226	2	36601880
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	4.20e-05	2	226	2	28483418
Pubmed	Kabuki Syndrome	KDM6A KMT2D	4.20e-05	2	226	2	21882399
Pubmed	PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program.	MED1 PRDM16	4.20e-05	2	226	2	25644604
Pubmed	Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.	KDM6A KMT2D	4.20e-05	2	226	2	30556359
Pubmed	Metabolic maintenance of cell asymmetry following division in activated T lymphocytes.	MYC TSC1	4.20e-05	2	226	2	27064903
Pubmed	The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization.	PRIMPOL USP36	4.20e-05	2	226	2	33237263
Pubmed	Iron-inhibited autophagy via transcription factor ZFP27 in Parkinson's disease.	ZNF585A ZNF585B	4.20e-05	2	226	2	37668106
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	4.20e-05	2	226	2	34156443
Pubmed	MLL2 and KDM6A mutations in patients with Kabuki syndrome.	KDM6A KMT2D	4.20e-05	2	226	2	23913813
Pubmed	Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons.	PLCB1 DAGLA	4.20e-05	2	226	2	24076015
Pubmed	Prenatal and perinatal history in Kabuki Syndrome.	KDM6A KMT2D	4.20e-05	2	226	2	31654559
Pubmed	Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription.	ELL2 AFF4	4.20e-05	2	226	2	28134250
Pubmed	The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.	KDM6A KMT2D	4.20e-05	2	226	2	31883305
Pubmed	SETting up the genome: KMT2D and KDM6A genomic function in the Kabuki syndrome craniofacial developmental disorder.	KDM6A KMT2D	4.20e-05	2	226	2	37800171
Pubmed	Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.	MYC BCAR1	4.20e-05	2	226	2	34192548
Interaction	YWHAH interactions	HIVEP2 SPAST AFTPH MYCBP2 BCAS3 TSC1 SOCS6 MAST2 BCR CEP170 FZR1 FAM117A MAST4 PIK3C2A AGFG1 NAV2 NAV1 PLEKHA7 BICC1 CDC42BPG TICRR TCF20 MINK1 ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 MED1 RGS12 FAF1 KIAA1671 NHSL1 PACS1 ARFGAP2 SNCAIP NCOA7 AKAP13 CEP131 SSH2 MARK2 FGD6	2.90e-14	1102	208	43	int:YWHAH
Interaction	YWHAG interactions	MYC HIVEP2 SPAST AFTPH MYCBP2 BCAS3 RC3H1 TSC1 SOCS6 MAST2 BCR TAOK2 CEP170 FZR1 FAM117A MAST4 PIK3C2A AGFG1 NAV2 NAV1 PLEKHA7 BICC1 TICRR MINK1 SH2D3C ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 RGS12 FAF1 TGOLN2 KIAA1671 NHSL1 PACS1 AKAP13 CEP131 SSH2 MARK2 FGD6	7.94e-12	1248	208	42	int:YWHAG
Interaction	YWHAQ interactions	MYC HIVEP2 AFTPH MYCBP2 RC3H1 TSC1 SOCS6 MAST2 BCR CEP170 FAM117A MAST4 USP42 PIK3C2A AGFG1 NAV2 NAV1 PLEKHA7 UNC79 BICC1 TICRR MINK1 ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 MED1 RGS12 KIAA1671 NHSL1 MTNR1B AKAP13 CEP131 SSH2 MARK2 CABIN1 FGD6	1.74e-11	1118	208	39	int:YWHAQ
Interaction	YWHAE interactions	MYC HIVEP2 MYCBP2 RC3H1 RAP1GAP2 TSC1 MAST2 BCR TAOK2 CEP170 FZR1 MAST4 PIK3C2A NAV2 NAV1 PLEKHA7 CAP2 TICRR MINK1 ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 RGS12 FAF1 TGOLN2 KIAA1671 PACS1 NCOR2 CDK13 AKAP13 CEP131 SSH2 MARK2 FGD6	6.59e-09	1256	208	37	int:YWHAE
Interaction	YWHAZ interactions	MYC HIVEP2 MYCBP2 RAP1GAP2 TSC1 ARID1A MAST2 BCR CEP170 FZR1 MAST4 PIK3C2A ZNF644 NAV2 NAV1 PLEKHA7 CDC42BPG TICRR CLIP2 MINK1 SH2D3C ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 RGS12 FAF1 KIAA1671 NHSL1 PACS1 AKAP13 CEP131 SSH2 MARK2 TNS1 FGD6	7.27e-09	1319	208	38	int:YWHAZ
Interaction	SOX7 interactions	ARID1A PRR12 KMT2C KDM6A TCF20 RBM20 TRIM33 NCOR2 KMT2D PRDM16	1.24e-08	82	208	10	int:SOX7
Interaction	YWHAB interactions	MYC MYCBP2 RC3H1 TSC1 MAST2 BCR CEP170 FAM117A MAST4 PIK3C2A NAV2 NAV1 PLEKHA7 TICRR MINK1 ZNF629 USP43 PARD3B RICTOR ALS2 BCAR1 RGS12 TGOLN2 KIAA1671 TRIM33 NHSL1 MTNR1B AKAP13 CEP131 SSH2 MARK2 FGD6	1.63e-08	1014	208	32	int:YWHAB
Interaction	FOXI1 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C KDM6A MLLT10 TRIM33 NCOR2 KMT2D	3.82e-08	92	208	10	int:FOXI1
Interaction	TOP3B interactions	SPHK2 HIVEP2 ZNF585A MYCBP2 BCAS3 RAP1GAP2 BCL9 ARID1A KLF4 ARHGEF11 MAST2 BCR TAOK2 PCNX2 PRR12 KMT2C FZR1 CLN3 NAV2 NAV1 PDZD8 RIPOR1 MICAL3 DLX2 KALRN MLLT10 ADGRA2 CIT NHSL1 NCOR2 KMT2D ZNF592 SETD5 CDK13 AKAP13 CEP131 CABIN1 DHX34 PRDM16	4.19e-08	1470	208	39	int:TOP3B
Interaction	SOX17 interactions	BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 TRIM33 NCOR2 KMT2D	5.20e-08	95	208	10	int:SOX17
Interaction	NFIA interactions	MYC BCL7C BCL9 ARID1A KLF4 TERF2IP PRR12 ZNF644 KDM6A CIT NCOR2 KMT2D SP7	8.19e-08	188	208	13	int:NFIA
Interaction	HNF4A interactions	BCL7C RAD54L2 ARID1A PRR12 KMT2C ZNF644 KDM6A ZNF629 MED1 TRIM33 YEATS2 NCOR2 KMT2D GTF3C2 CABIN1	1.85e-07	275	208	15	int:HNF4A
Interaction	FEV interactions	RAD54L2 BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 MLLT10 NCOR2 KMT2D GTF3C2 YY1AP1	2.00e-07	203	208	13	int:FEV
Interaction	EGR2 interactions	HIVEP2 RAD54L2 BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TRIM33 NCOR2 KMT2D PRDM16	2.22e-07	171	208	12	int:EGR2
Interaction	PAX8 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A CIT NCOR2 KMT2D	2.30e-07	111	208	10	int:PAX8
Interaction	NFIB interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A NCOR2 KMT2D SASS6 SP7	2.66e-07	142	208	11	int:NFIB
Interaction	TBR1 interactions	MYCBP2 BCL7C BCL9 ARID1A PRR12 KMT2C KDM6A NCOR2 KMT2D SP7	2.72e-07	113	208	10	int:TBR1
Interaction	TBXT interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 NCOR2 KMT2D	3.48e-07	116	208	10	int:TBXT
Interaction	SP7 interactions	MYC BCL7C BCL9 ARID1A PRR12 KMT2C RPRD2 DLX2 KDM6A TCF20 RBM20 TRIM33 NCOR2 KMT2D SP7	6.67e-07	304	208	15	int:SP7
Interaction	MAPRE3 interactions	NCKAP5 BCR TAOK2 CEP170 MAST4 NAV2 NAV1 CLIP2 MINK1 SYBU KIAA1671 CEP131 MARK2	8.34e-07	230	208	13	int:MAPRE3
Interaction	SFN interactions	MYC AFTPH MYCBP2 MAST2 BCR CEP170 MAST4 PIK3C2A NAV2 NAV1 PLEKHA7 MINK1 ZNF629 PARD3B RICTOR BCAR1 RGS12 KIAA1671 AKAP13 CEP131 SSH2 MARK2 FGD6	8.44e-07	692	208	23	int:SFN
Interaction	MYOD1 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TRIM33 NCOR2 KMT2D MYOCD CABIN1	8.63e-07	194	208	12	int:MYOD1
Interaction	PAX9 interactions	BCL9 ARID1A KLF4 PRR12 KMT2C ZNF644 KDM6A TCF20 NCOR2 KMT2D	1.00e-06	130	208	10	int:PAX9
Interaction	GSN interactions	MYC MYCBP2 BCL7C EYA1 BCL9 PIK3C2A USP36 DTNA SH2D3C RICTOR BCAR1 CIT	2.19e-06	212	208	12	int:GSN
Interaction	ERG interactions	BCL7C RAD54L2 BCL9 ARID1A PRR12 KMT2C KDM6A TCF20 MLLT10 TRIM33 NCOR2 KMT2D	3.70e-06	223	208	12	int:ERG
Interaction	SYNE3 interactions	RC3H1 TSC1 TAOK2 PIK3C2A NAV1 PDZD8 PLEKHA7 TCF20 GPATCH1 FBF1 PALB2 KIAA1671 YEATS2 NCOR2 ARFGAP2 CEP131 PBXIP1	3.89e-06	444	208	17	int:SYNE3
Interaction	RCOR1 interactions	MYC MYCBP2 MYT1 SOCS6 KLF4 BCR DNAJC6 TERF2IP KNL1 RBM20 PALB2 YEATS2 NCOR2 KMT2D ZNF592 CEP131 PRDM16 SP7	4.00e-06	494	208	18	int:RCOR1
Interaction	HNF1B interactions	BCL7C BCL9 ARID1A PRR12 KMT2C KDM6A MLLT10 NCOR2 KMT2D CABIN1 SP7	4.72e-06	190	208	11	int:HNF1B
Interaction	KDM1A interactions	MYC MYCBP2 MYT1 TSC1 SOCS6 BCR DNAJC6 ZBTB24 TERF2IP PRR12 ZNF644 NAV1 CNOT3 KNL1 TCF20 CIT RBM20 PALB2 KIAA1671 YEATS2 NCOR2 KMT2D GTF3C2 ZNF592 CEP131 SP7	4.83e-06	941	208	26	int:KDM1A
Interaction	PAX7 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A NCOR2 KMT2D	5.69e-06	124	208	9	int:PAX7
Interaction	SMG7 interactions	ZSWIM8 RC3H1 BCL9 ARID1A PRR12 RPRD2 CNOT3 TCF20 MLLT10 RBM20 YEATS2 NCOR2 KMT2D RBM5	6.17e-06	319	208	14	int:SMG7
Interaction	GCM1 interactions	BCL9 ARID1A PRR12 KMT2C KDM6A NCOR2 KMT2D	6.41e-06	68	208	7	int:GCM1
Interaction	BAG2 interactions	MYC RC3H1 DNAJC6 CEP170 FZR1 PIK3C2A RPRD2 KDM6A CNOT3 KNL1 USP36 TCF20 RICTOR CIT KIAA1671 TUBGCP6 TRIM33 YEATS2 ARFGAP2 GTF3C2	7.46e-06	622	208	20	int:BAG2
Interaction	AP2B1 interactions	MYC AFTPH RC3H1 BCR DNAJC6 TERF2IP PIK3C2A AGFG1 NAV1 USP36 CIT TGOLN2 KIAA1671 CEP131 AFF4	8.21e-06	373	208	15	int:AP2B1
Interaction	AFDN interactions	MYC SPAST SOCS6 BCR TAOK2 ADGRL2 PLEKHA7 MTUS2 DTNA MINK1 RICTOR KIAA1671 CEP131 MARK2	1.00e-05	333	208	14	int:AFDN
Interaction	CDC16 interactions	SPAST FZR1 PIK3C2A ZNF644 PYCR1 RICTOR TUBGCP6 TRIM33 YEATS2 MTNR1B YY1AP1 CEP131	1.01e-05	246	208	12	int:CDC16
Interaction	ASF1A interactions	MYC ARID1A ZNF644 SPTY2D1 TCF20 TRIM33 YEATS2 NCOR2 ARFGAP2 KMT2D ZNF592 CABIN1	1.14e-05	249	208	12	int:ASF1A
Interaction	LHX1 interactions	BCL7C BCL9 ARID1A KMT2C ZNF644 KDM6A NCOR2 KMT2D	1.16e-05	103	208	8	int:LHX1
Interaction	CRX interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 TRIM33 NCOR2 KMT2D PRDM16	1.39e-05	254	208	12	int:CRX
Interaction	KDM5C interactions	ASH1L TSC1 TERF2IP KDM6A EP400P1 PALB2 TRIM33 GTF3C2 ZNF592	1.44e-05	139	208	9	int:KDM5C
Interaction	TLX1 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 NCOR2 KMT2D	1.44e-05	175	208	10	int:TLX1
Interaction	ARHGEF2 interactions	MYC MYCBP2 TSC1 ASAP1 CEP170 FZR1 RICTOR BCAR1 CIT AKAP13 MARK2 PRDM16	1.50e-05	256	208	12	int:ARHGEF2
Interaction	PFN1 interactions	MYC TSC1 EYA1 ARHGEF11 BCR FZR1 PIK3C2A NAV1 MICAL3 USP36 MLLT10 KIAA1671 NHSL1 ARFGAP2 AKAP13 CEP131 AFF4	2.30e-05	509	208	17	int:PFN1
Interaction	SMARCA4 interactions	MYC BCL7C EYA1 ARID1A KLF4 TERF2IP KDM6A USP36 SALL4 CIT TRIM33 NCOR2 MYOCD BICRAL CABIN1 SP7	2.60e-05	462	208	16	int:SMARCA4
Interaction	H1-5 interactions	MYC SPAST EYA1 RAD54L2 PDZD8 RPRD2 DTNA PARD3B RICTOR MLLT10 CIT ZSCAN20 XIRP2 CDK13 RBM5 AFF4	2.67e-05	463	208	16	int:H1-5
Interaction	IRF4 interactions	ARID1A PRR12 KMT2C KDM6A TCF20 NCOR2 KMT2D	2.82e-05	85	208	7	int:IRF4
Interaction	HDAC1 interactions	MYC MYCBP2 BCAS3 MYT1 ARID1A KLF4 BCR DNAJC6 FZR1 NAV1 KNL1 USP36 TCF20 USP43 ARFGEF1 SALL4 CIT RBM20 PALB2 KIAA1671 YEATS2 NCOR2 KMT2D ZNF592 CEP131 CABIN1 PRDM16	2.98e-05	1108	208	27	int:HDAC1
Interaction	GSC interactions	BCL9 PRR12 KMT2C KDM6A NCOR2 KMT2D PRDM16	3.28e-05	87	208	7	int:GSC
Interaction	SNRNP40 interactions	MYC RC3H1 BCL9 ARID1A FZR1 USP42 ZNF644 PDZD8 SPTY2D1 KNL1 USP36 TCF20 SMARCAL1 GPATCH1 CIT RBM20 YEATS2 NCOR2 RBM5	3.57e-05	637	208	19	int:SNRNP40
Interaction	NUP35 interactions	RC3H1 BCL9 ARID1A PRR12 KMT2C PIK3C2A BICC1 TCF20 BCAR1 RBM20 TGOLN2 TRIM33 YEATS2 NCOR2 KMT2D	3.66e-05	424	208	15	int:NUP35
Interaction	TLE3 interactions	MYC HIVEP2 RAD54L2 BCL9 ARID1A PRR12 KNL1 TCF20 GPATCH1 MLLT10 RBM20 NCOR2 KMT2D SP7	3.85e-05	376	208	14	int:TLE3
Interaction	ZNF281 interactions	MYC KLF4 TERF2IP ZNF644 KDM6A SALL4 BCAR1 MED1 CIT SP7	3.98e-05	197	208	10	int:ZNF281
Interaction	KTN1 interactions	MYC SPAST MYCBP2 SOCS6 ARMCX2 ASAP1 PDZD8 RICTOR CIT TGOLN2 TRIM33 NCAN NEUROD6	4.24e-05	331	208	13	int:KTN1
Interaction	GATA2 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A MED1 NCOR2 KMT2D	4.34e-05	199	208	10	int:GATA2
Interaction	FBXO22 interactions	MYC GPN1 TSC1 KLF4 ARHGEF11 KMT2C NAV2 MICAL3 BCAR1 CIT RGS12 TGOLN2 NCOR2 XIRP2 ZNF592 MARK2 GALNT5	4.81e-05	540	208	17	int:FBXO22
Interaction	APC interactions	MYC SPAST MYCBP2 NCKAP5 KLF4 IL22RA1 ASAP1 AGFG1 NAV2 NAV1 RICTOR SASS6 AKAP13 MARK2	5.56e-05	389	208	14	int:APC
Interaction	LHX4 interactions	BCL7C BCL9 ARID1A KMT2C ZNF644 KDM6A TRIM33 NCOR2 KMT2D	5.85e-05	166	208	9	int:LHX4
Interaction	CEP162 interactions	CEP170 PYCR1 GPATCH1 FBF1 SYBU KIAA1671 YEATS2 SASS6 CEP131	6.42e-05	168	208	9	int:CEP162
Interaction	SOX9 interactions	BCL7C BCL9 ARID1A PRR12 KMT2C KDM6A KMT2D	6.60e-05	97	208	7	int:SOX9
Interaction	UBAP2L interactions	MYC RC3H1 TAOK2 FZR1 PIK3C2A CNOT3 BICC1 USP36 CIT TRIM33 YEATS2 MTNR1B	6.61e-05	298	208	12	int:UBAP2L
Interaction	KDM3A interactions	MYC MYCBP2 TERF2IP PDZD8 ARFGAP2 MYOCD	6.65e-05	67	208	6	int:KDM3A
Interaction	STX6 interactions	AFTPH TSC1 PIK3C2A AGFG1 PDZD8 ADGRL2 DTNA ARFGEF1 RICTOR TGOLN2 ARFGAP2 GTF3C2 NCOA7 MARK2 PBXIP1	6.83e-05	448	208	15	int:STX6
Interaction	ETV4 interactions	BCL9 ARID1A PRR12 KDM6A NCOR2 KMT2D	7.85e-05	69	208	6	int:ETV4
Interaction	FBXO42 interactions	TSC1 ARID1A ZNF644 AGFG1 NAV1 KNL1 DTNA KIAA1671 YEATS2 NCOR2 CEP131	8.32e-05	259	208	11	int:FBXO42
Interaction	PRIMPOL interactions	NAV1 PRIMPOL USP36 SMARCAL1	8.37e-05	23	208	4	int:PRIMPOL
Interaction	PLK1 interactions	MYC ZSWIM8 MYCBP2 MYT1 TSC1 EYA1 KLF4 BCR FZR1 FBF1 RICTOR BCAR1 MED1 PITPNM1 TRIM33 GTF3C2	8.40e-05	510	208	16	int:PLK1
Interaction	CTBP1 interactions	MYC BCAS3 KLF4 TERF2IP PRR12 PLCB1 SOBP FBF1 RICTOR MED1 YEATS2 NCOR2 ARFGAP2 PRDM16	8.77e-05	406	208	14	int:CTBP1
Interaction	RBM27 interactions	MYC RC3H1 TERF2IP USP36 CIT TRIM33 GTF3C2 SP7	9.01e-05	137	208	8	int:RBM27
Interaction	TEAD1 interactions	BCL7C ARID1A PRR12 KMT2C ZNF644 KDM6A CIT NCOR2 KMT2D	9.18e-05	176	208	9	int:TEAD1
Interaction	CLASP1 interactions	MYCBP2 TSC1 FZR1 CLIP2 SYBU CIT MTNR1B MARK2	9.48e-05	138	208	8	int:CLASP1
Interaction	AR interactions	MYC MYCBP2 BCL7C SOCS6 RAD54L2 BCL9 ARID1A KLF4 PRR12 KMT2C FZR1 RPRD2 KDM6A KNL1 CDC42BPG TCF20 SH2D3C MED1 TRIM33 NCOR2 KMT2D CEP131 TNS1 AFF4	9.53e-05	992	208	24	int:AR
Interaction	KCTD13 interactions	PDE1C BCAS3 TSC1 ARID1A ARHGEF11 BCR DNAJC6 ASAP1 CEP170 TTC7B PTPRZ1 NAV1 MICAL3 PLEKHA7 DAGLA MTUS2 CLIP2 KALRN MINK1 CIT FAF1 PITPNM1 NHSL1 PACS1 NCAN KNDC1 SSH2 MARK2 TNS1 PBXIP1	1.03e-04	1394	208	30	int:KCTD13
Interaction	CASK interactions	MYC DTNA PARD3B BCAR1 MED1 TGOLN2 ELL2 RBM5 MARK2 ARHGEF26	1.04e-04	221	208	10	int:CASK
Interaction	FAM90A26 interactions	FAM90A1 FAM90A26	1.06e-04	2	208	2	int:FAM90A26
Interaction	TLX2 interactions	BCL9 ARID1A PRR12 KMT2C ZNF644 TCF20 NCOR2 KMT2D	1.16e-04	142	208	8	int:TLX2
Interaction	ALG13 interactions	RC3H1 BCL9 ARID1A PRR12 USP36 TCF20 RBM20 NCOR2 KMT2D	1.24e-04	183	208	9	int:ALG13
Interaction	FBXW11 interactions	HIVEP2 TATDN2 KLF4 MAST2 PIK3C2A ZNF644 NAV1 KNL1 SYBU FAF1 ZIC2 TUBGCP6 WDR11 RBM5 AKAP13	1.25e-04	473	208	15	int:FBXW11
Interaction	SETD1B interactions	MYC KMT2C KDM6A BCAR1 YEATS2 KMT2D	1.25e-04	75	208	6	int:SETD1B
Interaction	NFIX interactions	BCL7C ARID1A PRR12 KMT2C ZNF644 KDM6A NCOR2 KMT2D GTF3C2 SP7	1.30e-04	227	208	10	int:NFIX
Interaction	LHX3 interactions	BCL9 ARID1A PRR12 KMT2C ZNF644 KDM6A TCF20 NCOR2 KMT2D	1.34e-04	185	208	9	int:LHX3
Interaction	RPRD2 interactions	MYC GPN1 RPRD2 RPS6KL1 MED1 POLR3E MTNR1B SP7	1.40e-04	146	208	8	int:RPRD2
Interaction	GATA3 interactions	BCL7C BCL9 ARID1A PRR12 KDM6A MED1 RBM20 NCOR2 KMT2D	1.46e-04	187	208	9	int:GATA3
Interaction	ELF5 interactions	BCL7C ARID1A KMT2C ZNF644 KDM6A SALL4 TRIM33 KMT2D	1.47e-04	147	208	8	int:ELF5
Interaction	CNOT9 interactions	MYC RC3H1 PIK3C2A RPRD2 CNOT3 MINK1 RBM20 KIAA1671 SASS6 CEP131	1.50e-04	231	208	10	int:CNOT9
Interaction	SDF4 interactions	MYC SOCS6 USP36 SH2D3C RICTOR TGOLN2 KIAA1671 TRIM33	1.77e-04	151	208	8	int:SDF4
Interaction	PAGR1 interactions	MYC KMT2C KDM6A KMT2D SP7	1.78e-04	51	208	5	int:PAGR1
Interaction	BCL7C interactions	MYC BCL7C ARID1A TERF2IP CAP2 BICRAL SP7	1.93e-04	115	208	7	int:BCL7C
Interaction	KLF5 interactions	BCL9 ARID1A PRR12 KMT2C KDM6A MLLT10 RBM20 NCOR2 KMT2D	1.99e-04	195	208	9	int:KLF5
Interaction	GTF3C4 interactions	MYC TERF2IP FZR1 ZNF644 USP36 CLIP2 SH2D3C CIT GTF3C2	1.99e-04	195	208	9	int:GTF3C4
Interaction	RPL28 interactions	MYC RC3H1 MATN2 ASH1L FZR1 ZNF644 PDZD8 SPTY2D1 USP36 CDC42BPG ZNF629 RICTOR FAM90A1 CIT GTF3C2	2.00e-04	494	208	15	int:RPL28
Interaction	TERF2IP interactions	MYC ARPP21 BCL7C ARID1A TERF2IP ZNF644 KNL1 TCF20 MED1 TRIM33 YEATS2 NCOR2 ZNF592 CDK13 RBM5 AFF4	2.08e-04	552	208	16	int:TERF2IP
Interaction	NELL2 interactions	MATN2 EMILIN2 CEP170 TGOLN2 TRIM33	2.14e-04	53	208	5	int:NELL2
Interaction	USP1 interactions	MYC TSC1 SOCS6 ARID1A BCR FZR1 USP43 BCAR1	2.21e-04	156	208	8	int:USP1
Interaction	NACA4P interactions	RICTOR BCAR1 CIT	2.23e-04	12	208	3	int:NACA4P
Interaction	DHX8 interactions	TERF2IP MYPN RPRD2 USP36 TCF20 GPATCH1 CIT CDK13 RBM5 DHX34 AFF4	2.37e-04	292	208	11	int:DHX8
Interaction	CHAF1B interactions	MYC TERF2IP FZR1 ZNF644 KNL1 BCAR1 CIT NCOR2	2.41e-04	158	208	8	int:CHAF1B
Interaction	TRMT1L interactions	MYC RC3H1 BCR FZR1 USP36 RICTOR BCAR1 CIT POLR3E	2.50e-04	201	208	9	int:TRMT1L
Interaction	PAX2 interactions	BCL9 PRR12 KMT2C KDM6A NCOR2 KMT2D	2.50e-04	85	208	6	int:PAX2
Interaction	COPB1 interactions	MYC ADAM19 FZR1 TCF20 RICTOR BCAR1 CIT TGOLN2 TRIM33 ARFGAP2 PRDM16	2.52e-04	294	208	11	int:COPB1
Interaction	CTNNA1 interactions	MYC BCR FMN1 PLEKHA7 DTNA CIT TGOLN2 KIAA1671 TRIM33 NHSL1 MTNR1B CEP131	2.73e-04	347	208	12	int:CTNNA1
Cytoband	8p23.1	FAM90A14 FAM90A17 FAM90A19 RP1L1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.96e-11	154	226	12	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	FAM90A14 FAM90A17 FAM90A19 RP1L1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	2.44e-09	234	226	12	chr8p23
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF11 BCR KALRN ALS2 AKAP13 ARHGEF26 FGD6	3.74e-07	66	126	7	722
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	ASH1L KMT2C KMT2D PRDM16	8.87e-05	34	126	4	487
GeneFamily	PDZ domain containing	ARHGEF11 MAST2 MAST4 PDZD8 PARD3B RGS12 FRMPD3	9.46e-05	152	126	7	1220
GeneFamily	PHD finger proteins	ASH1L KMT2C MLLT10 TRIM33 KMT2D	4.16e-04	90	126	5	88
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	HIVEP2 ZNF585A KLF4 ZBTB24 ZNF585B ZNF469 GLI4 ZNF629 SALL4 ZIC2 ZSCAN20 ZNF592 PRDM16 SP7	4.83e-04	718	126	14	28
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	BCR ASAP1 PLEKHA7 CDC42BPG AKAP13 ARHGEF26 FGD6	6.05e-04	206	126	7	682
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	DNAJC6 TNS1	1.31e-03	8	126	2	837
GeneFamily	ArfGAPs	ASAP1 AGFG1 ARFGAP2	1.55e-03	33	126	3	395
GeneFamily	AF4/FMR2 family\|Super elongation complex	ELL2 AFF4	1.68e-03	9	126	2	1280
Coexpression	HALLMARK_MITOTIC_SPINDLE	TSC1 ARHGEF11 BCR TAOK2 CLIP2 ARFGEF1 RICTOR ALS2 BCAR1 TUBGCP6 SASS6 AKAP13 CEP131 SSH2 FGD6	1.05e-10	199	214	15	M5893
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ARPP21 SPAST MYCBP2 MYT1 NUTM2A RAP1GAP2 TATDN2 SLC24A3 CSMD3 DNAJC6 CCDC85A TERF2IP MAST4 NAV1 CACNA1I MICAL3 UNC79 MTUS2 SOBP ARFGEF1 RICTOR SALL4 SYBU PACS1 CD2 NCAN NCOA7 SSH2 FRMPD3	3.14e-08	1106	214	29	M39071
Coexpression	MURARO_PANCREAS_BETA_CELL	HIVEP2 MYCBP2 ASH1L RAP1GAP2 BCL9 DNAJC6 TERF2IP ASAP1 KMT2C MAST4 TTC7B PIK3C2A PLCB1 NAV2 PDZD8 UNC79 MTUS2 PRUNE2 SOBP SYBU TGOLN2 PPP1R1A ARG2 NCOR2 TNS1 AFF4	6.92e-08	946	214	26	M39169
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	PDE1C TSC1 MAST2 CSMD3 DNAJC6 CCDC85A TERF2IP PLCB1 NAV1 UNC79 MTUS2 KALRN SOBP PALB2 ARG2 CD2 BICRAL SSH2	1.65e-06	584	214	18	M39068
Coexpression	GSE11057_CD4_CENT_MEM_VS_PBMC_UP	HIVEP2 ATXN7L1 ASH1L PCNX2 FAM117A MAST4 TCF20 PACS1 CD2 PBXIP1	5.70e-06	198	214	10	M3116
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	HIVEP2 AFTPH KREMEN1 ATXN7L1 DNAJC6 RPRD2 KMT2D GTF3C2 CDK13	6.07e-06	157	214	9	M7733
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	NCKAP5 MAST4 BICC1 PRUNE2 PARD3B FAF1 AKAP13 SSH2 ALPK2	1.52e-05	176	214	9	M39223
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYC HIVEP2 SPAST MYCBP2 SOCS6 MAST2 CEP170 PIK3C2A AGFG1 MICAL3 CAP2 ARFGEF1 MED1 TRIM33 NCOR2 ELL2 GTF3C2 CDK13 AKAP13 BICRAL	2.64e-05	856	214	20	M4500
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBM	MYT1 RAP1GAP2 CSMD3 TERF2IP NAV1 MTUS2 SOBP CD2 SHF NCAN NEUROD6	3.37e-05	295	214	11	M39063
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	PDE1C NCKAP5 EYA1 MICAL3 ADGRL2 MTUS2 CAP2 DTNA RBM20 TXLNB XIRP2 MYOCD PRDM16 ALPK2	4.85e-13	187	216	14	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	PDE1C ADAM19 NCKAP5 MAST4 MYPN MICAL3 MTUS2 CAP2 DTNA RBM20 XIRP2 MYOCD PRDM16 ALPK2	7.48e-13	193	216	14	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	NCKAP5 EYA1 MAST2 MAST4 MYPN MICAL3 CAP2 RBM20 ELL2 XIRP2 AKAP13 MYOCD ALPK2	9.85e-12	189	216	13	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	NCKAP5 EYA1 MAST2 MAST4 MYPN MICAL3 CAP2 RBM20 ELL2 XIRP2 AKAP13 MYOCD ALPK2	1.05e-11	190	216	13	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	PDE1C NCKAP5 MAST4 MYPN MICAL3 MTUS2 CAP2 DTNA RBM20 XIRP2 AKAP13 MYOCD ALPK2	1.46e-11	195	216	13	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	ADAM19 NCKAP5 MAST4 MYPN MICAL3 MTUS2 CAP2 DTNA RBM20 XIRP2 MYOCD ALPK2	1.03e-10	182	216	12	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	PDE1C MAST4 MICAL3 ADGRL2 MTUS2 DTNA RBM20 XIRP2 AKAP13 MYOCD PRDM16 ALPK2	1.59e-10	189	216	12	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	PDE1C NCKAP5 MAST4 MICAL3 ADGRL2 MTUS2 DTNA RBM20 AKAP13 MYOCD PRDM16 ALPK2	1.69e-10	190	216	12	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	NCKAP5 MAST2 MAST4 MYPN MICAL3 ADGRL2 MTUS2 CAP2 DTNA RBM20 MYOCD ALPK2	1.91e-10	192	216	12	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	MAST4 MICAL3 ADGRL2 MTUS2 CAP2 DTNA RBM20 TXLNB XIRP2 MYOCD PRDM16	2.22e-09	188	216	11	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	PDE1C NCKAP5 MAST2 MICAL3 ADGRL2 MTUS2 DTNA RBM20 MYOCD PRDM16 ALPK2	2.35e-09	189	216	11	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	RAP1GAP2 NCKAP5 MAST4 MYPN MICAL3 ADGRL2 MTUS2 DTNA RBM20 MYOCD ALPK2	2.62e-09	191	216	11	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	BCAS3 ATXN7L1 ASH1L NCKAP5 MAST4 PLEKHA7 BICC1 PARD3B FAF1 AKAP13 SSH2	2.77e-09	192	216	11	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1C FMN1 MYPN MTUS2 DTNA RBM20 TXLNB XIRP2 MYOCD ALPK2	1.15e-08	170	216	10	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IRGM MATN2 SLC24A3 RIPOR3 HOXA3 NAV2 BICC1 CLIP2 KALRN TNS1	2.84e-08	187	216	10	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ADAM19 RAP1GAP2 NCKAP5 MYPN ADGRL2 PRUNE2 DTNA RBM20 MYOCD ALPK2	2.99e-08	188	216	10	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN PLEKHA7 MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.15e-08	189	216	10	b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN PLEKHA7 MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.15e-08	189	216	10	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1C MYPN PLCB1 NAV1 MTUS2 KALRN DTNA RBM20 XIRP2 MYOCD	3.31e-08	190	216	10	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN PLEKHA7 MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.47e-08	191	216	10	97fb4232417a39801e87725755fd16a57c250209
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN PLEKHA7 MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.47e-08	191	216	10	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BCAS3 ASAP1 KMT2C FMN1 PLEKHA7 KDM6A FAF1 ELL2 AKAP13 SSH2	3.83e-08	193	216	10	779276e775cb2492e8dd36436295a536084a6415
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ADAM19 NCKAP5 MAST4 MYPN ADGRL2 MTUS2 PRUNE2 DTNA RBM20 ALPK2	4.03e-08	194	216	10	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	NCKAP5 MAST4 MYPN MICAL3 ADGRL2 MTUS2 DTNA RBM20 MYOCD ALPK2	4.03e-08	194	216	10	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	EYA1 MAST4 DTNA PARD3B KIAA1671 NHSL1 NCAN ARHGEF26 PRDM16 FGD6	5.36e-08	200	216	10	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1C ADAM19 MYPN MTUS2 DTNA RBM20 XIRP2 MYOCD ALPK2	2.64e-07	181	216	9	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1C MYPN MTUS2 DTNA RBM20 TXLNB XIRP2 MYOCD ALPK2	3.03e-07	184	216	9	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	facs-Heart-Unknown-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN MTUS2 RBM20 TXLNB XIRP2 MYOCD FRMPD3 ALPK2	3.47e-07	187	216	9	c004567767b89f3d89f5c7b28d952f3445957e1e
ToppCell	facs-Heart-Unknown-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN MTUS2 RBM20 TXLNB XIRP2 MYOCD FRMPD3 ALPK2	3.47e-07	187	216	9	0ffb988e0da2c7205c3515eca8e9851739bff5c5
ToppCell	facs-Heart-Unknown\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN MTUS2 RBM20 TXLNB XIRP2 MYOCD FRMPD3 ALPK2	3.47e-07	187	216	9	362e56426a568423a81e8a30e3ecf99b76135843
ToppCell	facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPHK2 ZNF644 GPATCH1 SALL4 RBM20 YEATS2 TXLNB XIRP2 MYOCD	3.63e-07	188	216	9	40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1
ToppCell	facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPHK2 ZNF644 GPATCH1 SALL4 RBM20 YEATS2 TXLNB XIRP2 MYOCD	3.63e-07	188	216	9	ba7f7ce034c0f42742bf2461f68f8d343ee593a5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 MAST4 MICAL3 PLEKHA7 BICC1 PRUNE2 DTNA KIAA1671 ALPK2	4.15e-07	191	216	9	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 MAST4 MICAL3 PLEKHA7 BICC1 PRUNE2 DTNA KIAA1671 ALPK2	4.15e-07	191	216	9	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	PDE1C NCKAP5 MYPN MTUS2 CAP2 DTNA RBM20 MYOCD ALPK2	4.94e-07	195	216	9	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE1C ADAM19 MICAL3 PRUNE2 KALRN DTNA ADGRA2 RBM20 MYOCD	5.38e-07	197	216	9	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC85A ASAP1 PIK3C2A NAV1 ADGRL2 KALRN SH2D3C NLRP1 NHSL1	5.61e-07	198	216	9	1378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE1C ASAP1 PLCB1 NAV1 ADGRL2 TBX1 KALRN SH2D3C EEPD1	5.85e-07	199	216	9	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	EYA1 MAST4 PARD3B KIAA1671 NHSL1 NCAN ARHGEF26 PRDM16 FGD6	6.10e-07	200	216	9	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	EYA1 MAST4 PARD3B KIAA1671 NHSL1 NCAN ARHGEF26 PRDM16 FGD6	6.10e-07	200	216	9	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	EYA1 MAST4 PARD3B KIAA1671 NHSL1 NCAN ARHGEF26 PRDM16 FGD6	6.10e-07	200	216	9	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	EYA1 MAST4 PARD3B KIAA1671 NHSL1 NCAN ARHGEF26 PRDM16 FGD6	6.10e-07	200	216	9	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	EYA1 MAST4 PARD3B KIAA1671 NHSL1 NCAN ARHGEF26 PRDM16 FGD6	6.10e-07	200	216	9	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	NCKAP5 CCDC85A NAV2 ADGRL2 PARD3B NCOA7 ARHGEF26 TNS1	1.86e-06	170	216	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	NCKAP5 FMN1 MYPN DTNA RBM20 TXLNB XIRP2 MYOCD	1.86e-06	170	216	8	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE1C SLC24A3 CSMD3 PTPRZ1 DLX2 SOBP CIT RGS12	1.95e-06	171	216	8	5efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MTUS2 PRUNE2 KALRN DTNA RBM20 MYOCD PRDM16 TNS1	2.12e-06	173	216	8	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAJC6 PLCB1 MICAL3 CAP2 KALRN RBM20 MYOCD TNS1	2.12e-06	173	216	8	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAM19 MYPN MTUS2 DTNA RBM20 XIRP2 MYOCD ALPK2	2.41e-06	176	216	8	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	LV\|World / Chamber and Cluster_Paper	PDE1C MAST4 ADGRL2 CAP2 RBM20 TXLNB XIRP2 PRDM16	2.85e-06	180	216	8	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	E18.5-samps-Mesenchymal-Pericyte\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MYC ARMCX2 BCR PTPRZ1 CAP2 TCTE1 MINK1 SH2D3C	2.85e-06	180	216	8	0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70
ToppCell	RV\|World / Chamber and Cluster_Paper	PDE1C EYA1 NAV1 MICAL3 CAP2 RBM20 XIRP2 PRDM16	2.97e-06	181	216	8	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C KLF4 CCDC85A ADGRL2 SH2D3C SYBU KIAA1671 EEPD1	3.23e-06	183	216	8	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1C MYPN MTUS2 DTNA RBM20 XIRP2 MYOCD ALPK2	3.50e-06	185	216	8	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	343B-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TSC1 SOCS6 BCL9 BCR PRR12 GPATCH1 TUBGCP6 NCOA7	3.50e-06	185	216	8	1b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell	343B-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TSC1 SOCS6 BCL9 BCR PRR12 GPATCH1 TUBGCP6 NCOA7	3.50e-06	185	216	8	02cbf492bc40abebaa93a3a208888afae72fbe06
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN PLEKHA7 MTUS2 RBM20 XIRP2 MYOCD ALPK2	3.64e-06	186	216	8	337f768cc43db2db96ba6495b076006b1a5b0331
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN PLEKHA7 MTUS2 RBM20 XIRP2 MYOCD ALPK2	3.64e-06	186	216	8	e378c82ef6d6cb24751515aa499a01372b3e7ccf
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C KLF4 CCDC85A ADGRL2 SH2D3C SYBU KIAA1671 EEPD1	3.78e-06	187	216	8	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN RBM20 TXLNB XIRP2 MYOCD FRMPD3 ALPK2	3.94e-06	188	216	8	4db566f3f708e66730aa9e16f4d73d91dc534177
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.94e-06	188	216	8	90dc0e15798d0b984518ad58c7e416e30aff687a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADAM19 NCKAP5 NAV2 CAP2 PRUNE2 DTNA PPP1R1A MYOCD	3.94e-06	188	216	8	f54b063025d80de631382bf5326bc40aab7f7d00
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.94e-06	188	216	8	f63dfd076ced81013918363282ae25cbbd8948ae
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	3.94e-06	188	216	8	0554d542149cef654ff1e5e32dfbffd8990b52bd
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN RBM20 TXLNB XIRP2 MYOCD FRMPD3 ALPK2	3.94e-06	188	216	8	6704b92991ad8c0a910e9f36cd33d00bd26dcb8f
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAM19 MICAL3 TBX1 KALRN SH2D3C BCAR1 KIAA1671 SNCAIP	3.94e-06	188	216	8	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	4.09e-06	189	216	8	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	4.09e-06	189	216	8	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 MICAL3 PLEKHA7 BICC1 PRUNE2 DTNA TNS1 ALPK2	4.09e-06	189	216	8	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1C MYT1 RIPOR3 MAST4 BICC1 PRUNE2 DTNA RGS12	4.26e-06	190	216	8	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C KLF4 CCDC85A ADGRL2 SH2D3C SYBU KIAA1671 EEPD1	4.26e-06	190	216	8	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C NCKAP5 KLF4 CCDC85A RIPOR1 SH2D3C KIAA1671 EEPD1	4.26e-06	190	216	8	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	PDE1C MAST4 ADGRL2 MTUS2 DTNA RBM20 AKAP13 PRDM16	4.26e-06	190	216	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1C MYT1 RIPOR3 MAST4 BICC1 PRUNE2 DTNA RGS12	4.26e-06	190	216	8	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE1C BCR CCDC85A ADGRL2 KALRN SH2D3C KIAA1671 EEPD1	4.26e-06	190	216	8	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	PDE1C MAST4 MYPN ADGRL2 MTUS2 DTNA RBM20 AKAP13	4.42e-06	191	216	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C KLF4 CCDC85A ADGRL2 SH2D3C SYBU KIAA1671 EEPD1	4.60e-06	192	216	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 ALPK2	4.60e-06	192	216	8	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 ALPK2	4.60e-06	192	216	8	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MATN2 PLCB1 MTUS2 BICC1 CAP2 SOBP SNCAIP TXLNB	4.78e-06	193	216	8	7cd9671e0ac64f7f3607f564485c63abbb7e7a63
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PTPRZ1 PLEKHA7 PARD3B NHSL1 NCAN ARHGEF26 PRDM16 PBXIP1	4.78e-06	193	216	8	40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC85A ASAP1 PIK3C2A NAV1 KALRN SH2D3C NLRP1 SNCAIP	4.78e-06	193	216	8	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PTPRZ1 PLEKHA7 PARD3B NHSL1 NCAN ARHGEF26 PRDM16 PBXIP1	4.78e-06	193	216	8	b03d908d4b8940927f72c76a1b0f237d13f39056
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM117A PLCB1 PYCR1 UNC79 SPTY2D1 SYBU EEPD1 GALNT5	4.78e-06	193	216	8	6a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C KLF4 CCDC85A RIPOR1 ADGRL2 SH2D3C KIAA1671 EEPD1	4.78e-06	193	216	8	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE1C KLF4 CCDC85A RIPOR1 ADGRL2 SH2D3C KIAA1671 EEPD1	4.78e-06	193	216	8	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	COPD-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	EMILIN2 RIPOR3 ITGAX FMN1 NHSL1 ELL2 AKAP13 DHX34	4.96e-06	194	216	8	7d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell	COPD-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	PLEKHA7 TBX1 KALRN PARD3B FAF1 KIAA1671 NHSL1 SNCAIP	5.15e-06	195	216	8	e91ce548ae7224661ee5d2f2639794a5f69798ee
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PCNX2 PLCB1 NAV2 NAV1 BICC1 SOBP PARD3B NCOR2	5.15e-06	195	216	8	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC85A ASAP1 PIK3C2A NAV1 KALRN SH2D3C NLRP1 SNCAIP	5.35e-06	196	216	8	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	5.35e-06	196	216	8	a582130862bee76c0385156a333bfdfc75cf218b
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYPN MTUS2 CAP2 RBM20 TXLNB XIRP2 MYOCD ALPK2	5.35e-06	196	216	8	fba52a4b82086dbae9a55038bf44c4539be926f5
ToppCell	Control-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	ADAM19 MICAL3 PLEKHA7 TBX1 KALRN PARD3B NHSL1 SNCAIP	5.35e-06	196	216	8	e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC85A ASAP1 PIK3C2A NAV1 KALRN SH2D3C NLRP1 SNCAIP	5.35e-06	196	216	8	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 ASAP1 PLCB1 MICAL3 TBX1 KALRN SH2D3C SNCAIP	5.76e-06	198	216	8	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 PLCB1 MICAL3 PRUNE2 KALRN DTNA RBM20 MYOCD	5.76e-06	198	216	8	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIVEP2 CSMD3 PLCB1 ADGRL2 UNC79 MTUS2 CAP2 KALRN	5.76e-06	198	216	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CSMD3 PLCB1 ADGRL2 UNC79 MTUS2 CAP2 KALRN SYBU	5.76e-06	198	216	8	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	BCAS3 FMN1 NAV2 PLEKHA7 KDM6A PARD3B FAF1 NHSL1	5.76e-06	198	216	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	MAST4 PLCB1 NAV2 PLEKHA7 USP36 SYBU NCOA7 AKAP13	5.76e-06	198	216	8	b8bd1ba268480f54451648e01631b615a3401144
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	HIVEP2 SLC24A3 ARMCX2 ASAP1 PLCB1 DLX2 DTNA MINK1 ARFGEF1 MLLT10 CDK13 BICRAL PRDM16	4.39e-08	197	212	13	2285_DN
Drug	Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; PC3; HT_HG-U133A	KLF4 TAOK2 RIPOR1 DAGLA KALRN DTNA PITPNM1 TRIM33 NCOR2 CEP131 DHX34	2.80e-06	199	212	11	7396_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	PDE1C HIVEP2 MAST4 NAV2 KDM6A ARFGEF1 TRIM33 YEATS2 CDK13 AKAP13	4.85e-06	171	212	10	7535_DN
Drug	troglitazone; Down 200; 10uM; PC3; HG-U133A	ARID1A TAOK2 PCNX2 CACNA1I CNOT3 RGS12 PACS1 AKAP13 CABIN1 TNS1	1.41e-05	193	212	10	431_DN
Drug	Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; MCF7; HT_HG-U133A	SPHK2 SOCS6 PLCB1 MICAL3 MINK1 MLLT10 PPP1R1A SIGLEC6 MARK2 DHX34	1.54e-05	195	212	10	7237_UP
Drug	trichostatin A; Up 200; 0.1uM; ssMCF7; HG-U133A	ZSWIM8 SLC24A3 SPTBN5 DLX2 CLIP2 MINK1 NLRP1 ADGRA2 ARG2 FGD6	1.61e-05	196	212	10	413_UP
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	MYT1 RAD54L2 MAST2 CLN3 CNOT3 CLIP2 NLRP1 AKAP13 MARK2 PBXIP1	1.61e-05	196	212	10	1323_UP
Drug	Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A	BCL9 KLF4 TAOK2 MICAL3 TGOLN2 PACS1 NCOR2 RBM5 MARK2 PBXIP1	1.61e-05	196	212	10	5288_UP
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	MYT1 RAD54L2 MAST2 CACNA1I MICAL3 DAGLA MINK1 PITPNM1 PACS1 TNS1	1.61e-05	196	212	10	6744_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SLC24A3 ARHGEF11 BCR FZR1 PLCB1 DAGLA KDM6A DOK1 DTNA RGS12	1.61e-05	196	212	10	4347_DN
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A	RAD54L2 BCL9 BCR FZR1 RPRD2 MICAL3 DTNA MLLT10 PACS1 AKAP13	1.61e-05	196	212	10	4802_DN
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	SLC24A3 ARID1A DNAJC6 TAOK2 PLCB1 MICAL3 DOK1 DTNA MINK1 AKAP13	1.68e-05	197	212	10	7484_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	RAD54L2 AGBL5 ASAP1 RIPOR1 USP36 TGOLN2 PACS1 AKAP13 MARK2 FGD6	1.68e-05	197	212	10	6930_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	SPHK2 TAOK2 MAST4 PLCB1 DTNA MINK1 NCOR2 SIGLEC6 DHX34 TNS1	1.68e-05	197	212	10	4764_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ADAM19 ASH1L TAOK2 FZR1 PLCB1 DAGLA MINK1 MLLT10 RGS12 AFF4	1.68e-05	197	212	10	3215_DN
Drug	Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; HL60; HT_HG-U133A	BCAS3 SLC24A3 ARHGEF11 IL22RA1 HOXA3 RIPOR1 PRUNE2 NLRP1 RGS12 CD2	1.68e-05	197	212	10	3138_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A	ZSWIM8 MYT1 ASH1L MAST2 SPTBN5 ADGRA2 SNCAIP SIGLEC6 NCAN DHX34	1.76e-05	198	212	10	4839_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	SPHK2 MAST2 AGFG1 PLCB1 KDM6A USP36 MINK1 NCOR2 RBM5 AKAP13	1.76e-05	198	212	10	4729_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A	HIVEP2 AGBL5 ARHGEF11 DOK1 DTNA ADGRA2 ARG2 GSDMD RBM5 PBXIP1	1.76e-05	198	212	10	1299_DN
Drug	Reserpinic acid hydrochloride; Up 200; 9.2uM; PC3; HT_HG-U133A	TAOK2 MAST4 CACNA1I PRUNE2 DTNA NLRP1 RGS12 PPP1R1A CD2 DHX34	1.76e-05	198	212	10	6603_UP
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	ASH1L SOCS6 ARID1A ARHGEF11 PLCB1 MINK1 NLRP1 MED1 AKAP13 TNS1	1.83e-05	199	212	10	7539_UP
Drug	Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MYC HIVEP2 DNAJC6 DLX2 KDM6A DTNA PACS1 RBM5 FGD6	2.92e-05	168	212	9	5310_UP
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	ARHGEF11 FZR1 FAM117A PLCB1 RIPOR1 SYBU PACS1 CDK13 MARK2	5.47e-05	182	212	9	7422_UP
Drug	0393-0188; Up 200; 10uM; PC3; HT_HG-U133A	ASH1L SOCS6 BCL9 KLF4 ARHGEF11 KDM6A MED1 AKAP13 TNS1	8.25e-05	192	212	9	7536_UP
Drug	Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A	ZSWIM8 SPHK2 SPTBN5 MAST4 DTNA RGS12 CDK13 ARHGEF26 TNS1	8.59e-05	193	212	9	4503_UP
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A	HIVEP2 ATXN7L1 ASH1L ARID1A BCR ARFGEF1 MLLT10 BICRAL MARK2	8.59e-05	193	212	9	6751_DN
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SLC24A3 DLX2 ADGRL2 DAGLA DTNA MINK1 ZNF592 FGD6 AFF4	8.59e-05	193	212	9	6209_UP
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	ASH1L TAOK2 CLN3 DTNA MLLT10 GTF3C2 GSDMD RBM5 PBXIP1	8.93e-05	194	212	9	1180_UP
Drug	Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	SPAST BCAS3 BCL9 FZR1 PLCB1 DTNA NLRP1 MLLT10 TNS1	8.93e-05	194	212	9	1267_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A	SLC24A3 SOCS6 RAD54L2 MAST4 DTNA MLLT10 ZNF592 CABIN1 DHX34	8.93e-05	194	212	9	3570_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A	FZR1 DAGLA RGS12 NCOR2 SNCAIP RBM5 AKAP13 DHX34 PBXIP1	8.93e-05	194	212	9	3855_UP
Drug	NS-398; Up 200; 10uM; MCF7; HT_HG-U133A	DNAJC6 MLLT10 RGS12 PACS1 CDK13 SIGLEC6 RBM5 ARHGEF26 DHX34	8.93e-05	194	212	9	6897_UP
Drug	Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A	ARHGEF11 MAST2 FZR1 MAST4 RGS12 NCOR2 SIGLEC6 RBM5 AFF4	8.93e-05	194	212	9	7164_UP
Drug	5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA	ARHGEF11 DNAJC6 RIPOR1 USP36 ZNF592 MARK2 CABIN1 ARHGEF26 DHX34	9.29e-05	195	212	9	898_DN
Drug	Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ADAM19 SLC24A3 MAST2 FZR1 MAST4 PLCB1 DTNA MINK1 PITPNM1	9.29e-05	195	212	9	7033_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ADAM19 ARID1A FZR1 MAST4 RIPOR1 MLLT10 RGS12 DHX34 PBXIP1	9.29e-05	195	212	9	7406_UP
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; PC3; HT_HG-U133A	MYT1 IL22RA1 CACNA1I PRUNE2 KALRN MINK1 NCOR2 SIGLEC6 DHX34	9.29e-05	195	212	9	4267_UP
Drug	Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A	RAD54L2 BCL9 KLF4 ASAP1 NAV2 SYBU MLLT10 RGS12 PACS1	9.66e-05	196	212	9	5301_UP
Drug	Aminohippuric acid [61-78-9]; Down 200; 20.6uM; HL60; HT_HG-U133A	ZSWIM8 SOCS6 AGBL5 BCR NLRP1 PITPNM1 GTF3C2 MARK2 DHX34	9.66e-05	196	212	9	3076_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A	ASH1L RAD54L2 PCNX2 FZR1 MICAL3 KDM6A PACS1 CEP131 CABIN1	9.66e-05	196	212	9	7228_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MYT1 RAD54L2 ARHGEF11 PCNX2 FZR1 USP36 RGS12 PACS1 RBM5	9.66e-05	196	212	9	3314_UP
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A	BCAS3 BCL9 DNAJC6 FZR1 CNOT3 SOBP PITPNM1 TNS1 PBXIP1	9.66e-05	196	212	9	5079_DN
Drug	Ribavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A	ARHGEF11 BCR TAOK2 FZR1 KDM6A MINK1 NLRP1 PACS1 SIGLEC6	9.66e-05	196	212	9	7316_UP
Drug	Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A	BCAS3 RAP1GAP2 KLF4 FZR1 NAV2 RIPOR1 CACNA1I MICAL3 PRUNE2	9.66e-05	196	212	9	3083_UP
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A	BCAS3 MICAL3 KDM6A DTNA MINK1 TRIM33 AKAP13 FGD6 PBXIP1	9.66e-05	196	212	9	7391_DN
Drug	F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A	MAST4 CACNA1I DLX2 PRUNE2 MINK1 RGS12 NCOR2 CDK13 PBXIP1	9.66e-05	196	212	9	6396_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	MYT1 MAST2 FZR1 RIPOR1 DLX2 MLLT10 PACS1 NCOR2 TNS1	1.00e-04	197	212	9	6737_DN
Drug	indomethacin, USP; Down 200; 100uM; SKMEL5; HG-U133A	ZSWIM8 SPTBN5 RIPOR1 DAGLA GPATCH1 MLLT10 HHLA1 RGS12 CEP131	1.00e-04	197	212	9	503_DN
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A	ZSWIM8 ARHGEF11 SPTBN5 PLCB1 DTNA MINK1 RGS12 PACS1 DHX34	1.00e-04	197	212	9	5415_DN
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A	BCAS3 MYT1 FZR1 MAST4 CACNA1I PACS1 NCOR2 DHX34 TNS1	1.00e-04	197	212	9	6732_DN
Drug	Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	SPHK2 SOCS6 CACNA1I MICAL3 DTNA MINK1 MARK2 PRDM16 AFF4	1.00e-04	197	212	9	3438_UP
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A	BCAS3 SOCS6 MAST2 FZR1 CLN3 DTNA NCOR2 ARHGEF26 AFF4	1.00e-04	197	212	9	4189_DN
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A	SPAST ARHGEF11 MAST2 BCR FZR1 NLRP1 ARG2 GSDMD SIGLEC6	1.00e-04	197	212	9	2483_DN
Drug	Primidone [125-33-7]; Up 200; 18.4uM; PC3; HT_HG-U133A	ZSWIM8 SOCS6 TAOK2 FZR1 PLCB1 KDM6A ARG2 NCOR2 SIGLEC6	1.00e-04	197	212	9	6723_UP
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	PDE1C MYT1 SLC24A3 ARHGEF11 MAST2 NAV2 MICAL3 DOK1 NCOR2	1.04e-04	198	212	9	7471_UP
Drug	Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	SPAST RAD54L2 ARMCX2 ARHGEF11 DAGLA KDM6A DTNA PACS1 CDK13	1.04e-04	198	212	9	7017_UP
Drug	Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	MAST2 FZR1 CLN3 RIPOR1 CACNA1I USP36 DTNA PACS1 DHX34	1.04e-04	198	212	9	7428_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	MAST4 CLN3 RIPOR1 MINK1 ZNF629 MLLT10 MARK2 ARHGEF26 PBXIP1	1.04e-04	198	212	9	7366_DN
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ARID1A FZR1 KDM6A DOK1 MINK1 PITPNM1 SIGLEC6 FGD6 AFF4	1.04e-04	198	212	9	1544_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A	ARMCX2 KLF4 FZR1 PACS1 NCOR2 CDK13 SIGLEC6 PBXIP1 AFF4	1.04e-04	198	212	9	1222_UP
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A	SPHK2 RAD54L2 PCNX2 CACNA1I MINK1 RGS12 NCOR2 RBM5 TNS1	1.08e-04	199	212	9	3287_UP
Drug	Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A	ZSWIM8 FZR1 BICC1 PRUNE2 DTNA NLRP1 SYBU MARK2 TNS1	1.08e-04	199	212	9	5526_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ADAM19 ARHGEF11 TAOK2 SPTBN5 FZR1 DLX2 ADGRA2 CD2 CDK13	1.08e-04	199	212	9	2329_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	FZR1 RIPOR1 ZNF629 NLRP1 MLLT10 PACS1 NCOR2 ZNF592 RBM5	1.08e-04	199	212	9	6321_DN
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	KLF4 ARHGEF11 BCR DAGLA SMARCAL1 ZNF592 CEP131 CABIN1 PBXIP1	1.13e-04	200	212	9	6947_DN
Drug	Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A	PDE1C RAD54L2 TAOK2 CACNA1I DAGLA RGS12 CABIN1 NEUROD6 DHX34	1.13e-04	200	212	9	2788_UP
Drug	DB04683	MINK1 ARFGEF1 WDR11 MRAP	1.89e-04	31	212	4	CID005288113
Drug	B5-9	BCR MINK1 WDR11 MRAP	2.14e-04	32	212	4	CID003001978
Drug	Methamphetamine	MYC ATXN7L1 MYT1 AGBL5 ARID1A MAST2 TAOK2 MICAL3 KDM6A SPTY2D1 PRUNE2 SH2D3C MLLT10 RBM20 ZIC2 ARG2 NCOR2 SHF POLR3E MTNR1B KNDC1 RBM5 AKAP13 CABIN1 PRDM16 TNS1 PBXIP1	2.71e-04	1401	212	27	ctd:D008694
Drug	salicylaldehyde	DLX2 CIT SHF YY1AP1	3.05e-04	35	212	4	CID000006998
Drug	Rifabutin [72559-06-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A	PDE1C ADAM19 ATXN7L1 ARMCX2 DNAJC6 DLX2 NLRP1 TNS1	3.05e-04	181	212	8	4349_UP
Drug	fullerene C60	ADAM19 BCAS3 ASH1L ARHGEF11 MAST2 IL22RA1 GJD4 PLCB1 RIPOR1 CACNA1I DLX2 DAGLA TBX1 CDC42BPG KALRN SH2D3C ZNF629 SYBU BCAR1 CIT RGS12 ARG2 PACS1 SETD5 EEPD1 NEUROD6 TNS1 AFF4	3.40e-04	1498	212	28	ctd:C069837
Drug	scriptaid; Up 200; 10uM; PC3; HT_HG-U133A	DNAJC6 AGFG1 DLX2 SOBP NLRP1 ARG2 AKAP13 PBXIP1	3.41e-04	184	212	8	6919_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	ARMCX2 DNAJC6 NAV2 DLX2 NLRP1 SYBU ARG2 PBXIP1	3.54e-04	185	212	8	6916_UP
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	RAD54L2 FZR1 FAM117A NAV2 CACNA1I DTNA RGS12 PBXIP1	3.80e-04	187	212	8	6984_UP
Drug	Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SPAST SOCS6 ARHGEF11 TAOK2 DLX2 DTNA CDK13 DHX34	4.08e-04	189	212	8	4401_DN
Drug	H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A	MYC HIVEP2 ARID1A KLF4 ZBTB24 GPATCH1 PALB2 RBM5	4.08e-04	189	212	8	5936_DN
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A	SLC24A3 FZR1 PLCB1 DLX2 PRUNE2 DTNA MINK1 RBM5	4.23e-04	190	212	8	2629_UP
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; HL60; HT_HG-U133A	MAST2 KDM6A DTNA NLRP1 MLLT10 GSDMD RBM5 PBXIP1	4.38e-04	191	212	8	2466_DN
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A	KLF4 BCR TAOK2 SMARCAL1 PACS1 SIGLEC6 CABIN1 PBXIP1	4.38e-04	191	212	8	5290_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	MYC RAD54L2 BCL9 KLF4 DLX2 MINK1 YEATS2 DHX34	4.38e-04	191	212	8	5210_DN
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A	ARMCX2 ARID1A CLN3 PLCB1 DAGLA DTNA RBM5 DHX34	4.53e-04	192	212	8	5216_UP
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A	TAOK2 FZR1 NAV2 KDM6A CNOT3 NLRP1 SNCAIP PRDM16	4.53e-04	192	212	8	4108_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	MYC ZSWIM8 ARID1A MAST4 RIPOR1 DLX2 MINK1 DHX34	4.53e-04	192	212	8	5222_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A	SOCS6 RAD54L2 ARID1A MLLT10 CDK13 DHX34 FGD6 AFF4	4.53e-04	192	212	8	6659_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	RIPOR1 DTNA ADGRA2 NCOR2 SIGLEC6 CEP131 DHX34 TNS1	4.53e-04	192	212	8	2699_DN
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	MYC ARID1A KLF4 MAST4 RIPOR1 SOBP SMARCAL1 DHX34	4.53e-04	192	212	8	1638_DN
Drug	Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A	ARHGEF11 BCR FZR1 KDM6A MINK1 ARG2 ZNF592 RBM5	4.53e-04	192	212	8	7378_DN
Drug	Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	PLCB1 MICAL3 DTNA MINK1 RGS12 PPP1R1A CDK13 PBXIP1	4.53e-04	192	212	8	7191_UP
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	ARHGEF11 NAV2 DLX2 DAGLA PRUNE2 KALRN MINK1 DHX34	4.53e-04	192	212	8	4303_UP
Drug	Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A	ATXN7L1 RAP1GAP2 TAOK2 MAST4 USP36 MLLT10 RBM5 TNS1	4.69e-04	193	212	8	7059_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; MCF7; HT_HG-U133A	SLC24A3 SOCS6 PLCB1 DAGLA MINK1 RGS12 PACS1 SIGLEC6	4.69e-04	193	212	8	3221_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A	BCAS3 ATXN7L1 FZR1 DTNA ARG2 CDK13 AKAP13 TNS1	4.69e-04	193	212	8	3773_DN
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SPHK2 SOCS6 TAOK2 MICAL3 KDM6A DTNA RBM5 MARK2	4.69e-04	193	212	8	5430_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	KLF4 MAST2 PCNX2 NAV2 DAGLA SIGLEC6 TNS1 PBXIP1	4.69e-04	193	212	8	4712_UP
Drug	trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A	MYC SLC24A3 ARID1A RPRD2 DAGLA MLLT10 TRIM33 RBM5	4.69e-04	193	212	8	413_DN
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	SLC24A3 SOCS6 BCL9 FAM117A PITPNM1 PACS1 RBM5 AKAP13	4.69e-04	193	212	8	1657_UP
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	ATXN7L1 MAST2 BCR TAOK2 MAST4 DLX2 TRIM33 PBXIP1	4.69e-04	193	212	8	5119_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; HL60; HT_HG-U133A	HIVEP2 SOCS6 BCR PCNX2 FZR1 NLRP1 MLLT10 PBXIP1	4.85e-04	194	212	8	3015_DN
Drug	Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A	ZSWIM8 BCR TAOK2 CNOT3 TBX1 DTNA KMT2D SIGLEC6	4.85e-04	194	212	8	6696_UP
Disease	cortical surface area measurement	MYCBP2 MYT1 NCKAP5 EYA1 AGBL5 MAST2 BCR ZNF469 MAST4 AGFG1 NAV2 NAV1 ADGRL2 PLEKHA7 RPS6KL1 TICRR PARD3B SYBU ADGRA2 FAF1 TGOLN2 NHSL1 RP1L1 C6orf15 SSH2 TNS1 FGD6 SP7	4.14e-07	1345	211	28	EFO_0010736
Disease	serum gamma-glutamyl transferase measurement	ARPP21 ASH1L ARID1A ARHGEF11 CSMD3 NAV2 MICAL3 ADGRL2 BICC1 SEC16B KALRN GPATCH1 NLRP1 CIT FAF1 NCOR2 RP1L1 AKAP13 YY1AP1 CABIN1 ALPK2	2.87e-06	914	211	21	EFO_0004532
Disease	C-reactive protein measurement	ZSWIM8 AHI1-DT ADAM19 ARPP21 RIPOR3 AGBL5 DNAJC6 IL22RA1 ZNF469 ZNF644 MICAL3 DAGLA SEC16B RICTOR MLLT10 CIT YEATS2 PACS1 GTF3C2 SETD5 GSDMD EEPD1 RP1L1 AFF4	6.37e-06	1206	211	24	EFO_0004458
Disease	Bladder Neoplasm	MYC TSC1 ARID1A ASAP1 KMT2C KDM6A KMT2D NCAN	7.97e-06	140	211	8	C0005695
Disease	Malignant neoplasm of urinary bladder	MYC TSC1 ARID1A ASAP1 KMT2C KDM6A KMT2D NCAN	8.40e-06	141	211	8	C0005684
Disease	uric acid measurement	BCAS3 ARID1A QRICH2 FMN1 NAV1 ADGRL2 BICC1 CDC42BPG FAF1 PACS1 SHF NCOA7 AKAP13 ARHGEF26 MTX1 NEUROD6	9.18e-06	610	211	16	EFO_0004761
Disease	Congenital Heart Defects	EYA1 KLF4 HOXA3 TBX1 AFF4	1.54e-05	44	211	5	C0018798
Disease	forced expiratory volume	ADAM19 BCAS3 BCL9 ZBTB24 HOXA3 MYPN RPRD2 MICAL3 ADGRL2 ZNF629 PARD3B MED1 RBM20 FAF1 NCOR2 WDR11 TNS1 FGD6	1.66e-05	789	211	18	EFO_0004314
Disease	FEV/FEC ratio	PDE1C ADAM19 HIVEP2 KREMEN1 BCAS3 SLC24A3 EYA1 ASAP1 SPTBN5 PRR12 TTC7B NAV2 NAV1 RIPOR1 MICAL3 TBX1 FAF1 TRIM33 SSH2 ARHGEF26 PRDM16 TNS1 FGD6	2.62e-05	1228	211	23	EFO_0004713
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	MYC BCR KDM6A CNOT3 MLLT10	3.87e-05	53	211	5	C1961099
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	5.09e-05	2	211	2	DOID:0080598 (implicated_via_orthology)
Disease	Kabuki syndrome 1	KDM6A KMT2D	5.09e-05	2	211	2	cv:CN030661
Disease	Kabuki syndrome (is_implicated_in)	KDM6A KMT2D	5.09e-05	2	211	2	DOID:0060473 (is_implicated_in)
Disease	KABUKI SYNDROME 1	KDM6A KMT2D	5.09e-05	2	211	2	147920
Disease	cortical thickness	MYCBP2 NCKAP5 EYA1 MAST2 ZNF469 MAST4 GLI4 NAV2 NAV1 MICAL3 PLEKHA7 SMARCAL1 SYBU MLLT10 ADGRA2 FAF1 NHSL1 SHF SETD5 SSH2 TNS1	5.38e-05	1113	211	21	EFO_0004840
Disease	breast cancer (is_marker_for)	BCAS3 TSC1 KDM6A BCAR1 NCOR2 KMT2D SETD5 CDK13	5.92e-05	185	211	8	DOID:1612 (is_marker_for)
Disease	polychlorinated biphenyls measurement, gestational serum measurement	NCKAP5 FMN1 BICC1	7.56e-05	12	211	3	EFO_0007042, EFO_0007964
Disease	Kabuki syndrome (implicated_via_orthology)	KDM6A KMT2D	1.52e-04	3	211	2	DOID:0060473 (implicated_via_orthology)
Disease	breast ductal carcinoma (is_implicated_in)	RICTOR BCAR1	1.52e-04	3	211	2	DOID:3007 (is_implicated_in)
Disease	Prostatic Neoplasms	MYC ASH1L ARID1A KMT2C RPRD2 KDM6A CNOT3 BCAR1 PALB2 ZIC2 ARG2 KMT2D NCOA7 AKAP13	1.53e-04	616	211	14	C0033578
Disease	Malignant neoplasm of prostate	MYC ASH1L ARID1A KMT2C RPRD2 KDM6A CNOT3 BCAR1 PALB2 ZIC2 ARG2 KMT2D NCOA7 AKAP13	1.53e-04	616	211	14	C0376358
Disease	neutrophil count	SPHK2 ADAM19 HIVEP2 MYCBP2 RC3H1 ASH1L RIPOR3 BCL9 ARID1A MAST2 HOXA3 PLCB1 RPRD2 ADGRL2 PRUNE2 CIT TGOLN2 TRIM33 RP1L1 AKAP13 YY1AP1 SSH2 SP7	1.55e-04	1382	211	23	EFO_0004833
Disease	psoriasis	SPHK2 ADAM19 RAP1GAP2 TSC1 SPATA31C1 MYPN SPATA31C2 C6orf15 AKAP13	1.65e-04	273	211	9	EFO_0000676
Disease	brain aneurysm	SLC24A3 MINK1 PARD3B BCAR1 RP1L1 FGD6	1.67e-04	113	211	6	EFO_0003870
Disease	neuroimaging measurement, brain volume measurement	NCKAP5 ARHGEF11 MAST4 GPATCH1 MLLT10 FAF1 NCOA7 NEUROD6 PRDM16	2.33e-04	286	211	9	EFO_0004346, EFO_0006930
Disease	PR interval	MYCBP2 EMILIN2 RAP1GAP2 NCKAP5 GJD4 ZNF469 NAV2 KALRN DTNA MINK1 FAF1 MYOCD	2.54e-04	495	211	12	EFO_0004462
Disease	Familial dilated cardiomyopathy	MYPN CAP2 RBM20 PRDM16	2.76e-04	44	211	4	C0340427
Disease	esophagus squamous cell carcinoma (is_implicated_in)	KMT2C KDM6A RICTOR KMT2D	3.01e-04	45	211	4	DOID:3748 (is_implicated_in)
Disease	Kabuki make-up syndrome	KDM6A KMT2D	3.02e-04	4	211	2	C0796004
Disease	hippocampal tail volume	MAST4 FAF1 NEUROD6	3.21e-04	19	211	3	EFO_0009398
Disease	white matter hyperintensity measurement	PDE1C ARID1A QRICH2 CCDC85A FBF1 NCOR2 SNCAIP PRDM16 FGD6	3.47e-04	302	211	9	EFO_0005665
Disease	platelet component distribution width	HIVEP2 KREMEN1 MYT1 RIPOR3 ASAP1 CLN3 PLCB1 PRUNE2 KALRN ZNF629 TRIM33 NCOR2 AKAP13 PRDM16 FGD6	3.78e-04	755	211	15	EFO_0007984
Disease	neutrophil percentage of leukocytes	SPHK2 ADAM19 RAP1GAP2 ARID1A HOXA3 PLCB1 KALRN MINK1 SH2D3C FAF1 TGOLN2 CDK13 AKAP13	4.84e-04	610	211	13	EFO_0007990
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	5.02e-04	5	211	2	C0206630
Disease	adenoid cystic carcinoma (is_implicated_in)	KMT2C KDM6A	5.02e-04	5	211	2	DOID:0080202 (is_implicated_in)
Disease	Klatskin's tumor (is_implicated_in)	ARID1A KMT2C	5.02e-04	5	211	2	DOID:4927 (is_implicated_in)
Disease	Autosomal Recessive Primary Microcephaly	KNL1 CIT SASS6	5.02e-04	22	211	3	C3711387
Disease	Primary microcephaly	KNL1 CIT TUBGCP6	5.02e-04	22	211	3	C0431350
Disease	hypertrophic cardiomyopathy	NCKAP5 KMT2C MTUS2 PARD3B ZNF592	5.29e-04	92	211	5	EFO_0000538
Disease	Neurodevelopmental Disorders	SPAST ASH1L KMT2C PARD3B SETD5	5.56e-04	93	211	5	C1535926
Disease	reticulocyte measurement	SPHK2 KREMEN1 ASH1L EYA1 ITGAX FZR1 ZNF469 USP42 PLCB1 PLEKHA7 RICTOR FAF1 PACS1 EEPD1 NCOA7 AKAP13 PRDM16 TNS1	6.03e-04	1053	211	18	EFO_0010700
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TSC1 ARID1A CSMD3 KDM6A MLLT10 AKAP13	7.07e-04	148	211	6	C0279702
Disease	migraine disorder, diastolic blood pressure	SLC24A3 NCOR2 PRDM16	7.38e-04	25	211	3	EFO_0006336, MONDO_0005277
Disease	Clear cell sarcoma of kidney	NUTM2B NUTM2E	7.49e-04	6	211	2	C0334488
Disease	renal overload-type gout	SPATA31C1 SPATA31C2	7.49e-04	6	211	2	EFO_0021525
Disease	eye disease (implicated_via_orthology)	EYA1 RP1L1	7.49e-04	6	211	2	DOID:5614 (implicated_via_orthology)
Disease	Adenoid Cystic Carcinoma	SLC24A3 ARID1A KMT2C KDM6A MARK2	7.74e-04	100	211	5	C0010606
Disease	Sezary Syndrome	ARID1A KMT2C KMT2D	9.29e-04	27	211	3	C0036920
Disease	prostate cancer (is_marker_for)	MYC KMT2C KDM6A KMT2D SETD5 CDK13	9.29e-04	156	211	6	DOID:10283 (is_marker_for)
Disease	fat body mass	SPATA31E1 MYCBP2 SPATA31C1 CAP2 PRUNE2 SEC16B PPP1R1A	9.96e-04	217	211	7	EFO_0005409
Disease	lung small cell carcinoma (is_implicated_in)	KDM6A RICTOR KMT2D	1.03e-03	28	211	3	DOID:5409 (is_implicated_in)
Disease	cognitive function measurement, self reported educational attainment	PDE1C ARPP21 MYCBP2 PRR12 CACNA1I KNL1 TCF20 C6orf15 RBM5	1.10e-03	355	211	9	EFO_0004784, EFO_0008354
Disease	Liver carcinoma	MYC TSC1 ARID1A DNAJC6 KMT2C CAP2 TICRR MED1 ZIC2 PPP1R1A CEP131	1.13e-03	507	211	11	C2239176
Disease	migraine disorder	SLC24A3 EYA1 ASAP1 BICC1 NLRP1 MLLT10 RBM20 NCOR2 PRDM16	1.14e-03	357	211	9	MONDO_0005277
Disease	eosinophil cationic protein measurement	SPATA31C1 SPATA31C2	1.39e-03	8	211	2	EFO_0010913
Disease	breast cancer anti-estrogen resistance protein 3 measurement	SH2D3C BCAR1	1.39e-03	8	211	2	EFO_0008040
Disease	schizophrenia (implicated_via_orthology)	HIVEP2 CSMD3 PLCB1 ZIC2	1.45e-03	68	211	4	DOID:5419 (implicated_via_orthology)
Disease	vital capacity	AHI1-DT HIVEP2 MYT1 ZBTB24 HOXA3 MYPN PLCB1 RIPOR1 RPRD2 MICAL3 ADGRL2 DAGLA TCF20 ZNF629 MLLT10 MED1 RBM20 NCOR2 TNS1	1.49e-03	1236	211	19	EFO_0004312
Disease	congenital heart disease (implicated_via_orthology)	KMT2C USP42 USP36 KMT2D	1.53e-03	69	211	4	DOID:1682 (implicated_via_orthology)
Disease	response to aromatase inhibitor	ATXN7L1 MATN2 MUC16	1.53e-03	32	211	3	GO_0061477
Disease	longitudinal alcohol consumption measurement	SPATA31C1 SPATA31C2	1.77e-03	9	211	2	EFO_0007645
Disease	Polycystic Kidney, Autosomal Dominant	MYC BICC1	1.77e-03	9	211	2	C0085413
Disease	Coffin-Siris syndrome (implicated_via_orthology)	ARID1A BICRAL	1.77e-03	9	211	2	DOID:1925 (implicated_via_orthology)
Disease	bullous pemphigoid	EMILIN2 MAST4 CLN3	1.83e-03	34	211	3	EFO_0007187
Disease	esophagus squamous cell carcinoma (is_marker_for)	KDM6A RICTOR KMT2D SETD5	1.98e-03	74	211	4	DOID:3748 (is_marker_for)
Disease	urate measurement	BCAS3 ASH1L ARID1A QRICH2 FMN1 NAV1 ADGRL2 BICC1 CDC42BPG DTNA FAF1 NCOA7 AKAP13 ARHGEF26 MTX1	2.07e-03	895	211	15	EFO_0004531
Disease	testosterone measurement	BCL7C SLC24A3 EYA1 ARID1A CSMD3 MYPN PLCB1 ADGRL2 CAP2 KNL1 ZNF629 USP43 FAF1 NCOR2 GTF3C2 WDR11 KNDC1 MYOCD YY1AP1	2.11e-03	1275	211	19	EFO_0004908
Disease	brain measurement, neuroimaging measurement	NCKAP5 MAST4 NAV2 GPATCH1 MLLT10 FAF1 NHSL1 SSH2 PRDM16 TNS1 FGD6	2.15e-03	550	211	11	EFO_0004346, EFO_0004464
Disease	Burkitt Lymphoma	MYC ARID1A BCR	2.16e-03	36	211	3	C0006413
Disease	Asymmetric crying face association	EYA1 TBX1	2.21e-03	10	211	2	C0431406
Disease	creatinine measurement	BCAS3 EYA1 ARID1A KLF4 MAST2 MYPN ADGRL2 PLEKHA7 MED1 RGS12 ARG2 SHF ZNF592 NCOA7 ARHGEF26 MTX1	2.24e-03	995	211	16	EFO_0004518
Disease	orofacial cleft	BEST3 FMN1 ZIC2	2.34e-03	37	211	3	MONDO_0000358
Disease	coronary artery disease	PDE1C ADAM19 HIVEP2 BCAS3 MAST4 RPRD2 ADGRL2 PLEKHA7 BICC1 FBF1 USP43 BCAR1 AKAP13 CABIN1 ARHGEF26 PRDM16 TNS1 FGD6	2.44e-03	1194	211	18	EFO_0001645
Disease	brain connectivity measurement	NCKAP5 MAST2 NAV2 RPRD2 MTUS2 MLLT10 FAF1 NHSL1 SSH2	2.47e-03	400	211	9	EFO_0005210
Disease	Cardiomyopathies	MYPN DTNA RBM20 PPP1R1A MYOCD	2.48e-03	130	211	5	C0878544
Disease	Ductal Carcinoma	MYC BCAR1	2.68e-03	11	211	2	C1176475
Disease	Congenital Abnormality	EYA1 KLF4	2.68e-03	11	211	2	C0000768
Disease	nucleus accumbens volume change measurement	MUC16 NEUROD6	2.68e-03	11	211	2	EFO_0021493
Disease	hypospadias	EYA1 HOXA3 SP7	2.73e-03	39	211	3	EFO_0004209
Disease	Lewy body dementia	BCL7C ASH1L DHX34	2.73e-03	39	211	3	EFO_0006792
Disease	Hodgkins lymphoma	PRR12 CACNA1I SH2D3C TEX55	2.88e-03	82	211	4	EFO_0000183
Disease	reaction time measurement	RAP1GAP2 NCKAP5 CCDC85A PTPRZ1 NAV2 ADGRL2 RPS6KL1 CAP2 NLRP1 PARD3B ARFGAP2 KMT2D	2.92e-03	658	211	12	EFO_0008393
Disease	Agents acting on the renin-angiotensin system use measurement	BCAS3 MYT1 ARID1A PLCB1 BICC1 TICRR RGS12 PRDM16	2.96e-03	335	211	8	EFO_0009931
Disease	Congenital small ears	EYA1 KDM6A KMT2D	3.15e-03	41	211	3	C0152423
Disease	Carcinoma, Transitional Cell	ARID1A KMT2C KDM6A	3.15e-03	41	211	3	C0007138
Disease	waist-hip ratio	ARPP21 MYCBP2 ATXN7L1 EMILIN2 EYA1 TAOK2 MAST4 PDZD8 KNL1 PRUNE2 SEC16B ARFGEF1 MLLT10 TRIM33 YEATS2 WDR11 ARHGEF26 PRDM16	3.22e-03	1226	211	18	EFO_0004343
Disease	mean arterial pressure	HOXA3 CEP170 PLEKHA7 USP36 TCF20 BCAR1 YEATS2 MTX1 PRDM16 TNS1	3.33e-03	499	211	10	EFO_0006340
Disease	migraine disorder, Headache	SLC24A3 RPRD2 BCAR1 PRDM16	3.42e-03	86	211	4	HP_0002315, MONDO_0005277
Disease	alcohol consumption measurement	GPN1 NCKAP5 CSMD3 SPTBN5 MAST4 CLN3 PLCB1 CACNA1I RPRD2 MICAL3 ADGRL2 MED1 CIT RGS12 FAF1 NCOR2 PRDM16 AFF4	3.69e-03	1242	211	18	EFO_0007878
Disease	ascorbic acid 2-sulfate measurement	TAOK2 ZG16	3.77e-03	13	211	2	EFO_0800169
Disease	egg allergy measurement, parental genotype effect measurement	SPATA31C1 SPATA31C2	3.77e-03	13	211	2	EFO_0005939, EFO_0007018
Disease	intraocular pressure measurement	KREMEN1 BCAS3 ZNF469 PLEKHA7 BICC1 KALRN PARD3B AKAP13 PRDM16 TNS1	3.83e-03	509	211	10	EFO_0004695
Disease	cholesteryl ester 20:4 measurement	NAV2 DAGLA NHSL1	3.85e-03	44	211	3	EFO_0010348
Disease	obsolete_red blood cell distribution width	SPHK2 BCAS3 RC3H1 ITGAX ZBTB24 CEP170 FZR1 FAM117A MAST4 DAGLA KNL1 USP36 KALRN CIT TRIM33 EEPD1 RP1L1 AKAP13 SP7	3.85e-03	1347	211	19	EFO_0005192
Disease	cup-to-disc ratio measurement	BCAS3 EYA1 ASAP1 MYPN NAV2 BICC1 SNCAIP MARK2 PRDM16	3.97e-03	430	211	9	EFO_0006939
Disease	lymphocyte count	SPHK2 SPAST BCAS3 BCL7C RAP1GAP2 RIPOR3 ARHGEF11 BCR HOXA3 ZNF469 ZNF644 PLCB1 RIPOR1 MICAL3 KNL1 KALRN MINK1 FAF1 CDK13 SSH2	4.35e-03	1464	211	20	EFO_0004587
Disease	ventricular septal defect (is_implicated_in)	TBX1 SALL4	4.38e-03	14	211	2	DOID:1657 (is_implicated_in)
Disease	whole-brain volume, Alzheimer's disease biomarker measurement	BICC1 EEPD1	4.38e-03	14	211	2	EFO_0005089, EFO_0006514
Disease	early cardiac repolarization measurement	MYCBP2 PDZD8	4.38e-03	14	211	2	EFO_0004885
Disease	Left ventricular noncompaction	DTNA PRDM16	4.38e-03	14	211	2	C1960469

Protein segments in the cluster

Peptide	Gene	Start	Entry
LGSSHTSLGNLSPDP	BEST3	596	Q8N1M1
SPAPTSSGPASSHKL	AGBL5	721	Q8NDL9
QPPEKNSGHSTSKGD	CEP170	786	Q5SW79
ASAPPSSSPGRSHSK	ASH1L	1741	Q9NR48
PTLNGHLNPTSEKSA	ELL2	346	O00472
PLTTSSGNLHGQPVS	ARG2	151	P78540
VSRGKAPSSPGGSTH	BLACE	81	A4D250
SKDGLSPHPADTQST	CSMD3	411	Q7Z407
EGGGTLHPNPTDKTS	BCAR1	616	P56945
GDNLPENHSGSKTPV	ALS2	646	Q96Q42
SHSNTSRPGAAGPGK	ADGRA2	656	Q96PE1
SLKSSPSGSSGHPLA	ADGRA2	1116	Q96PE1
IDDSPSSSPHLSSKG	BCR	456	P11274
GTPRSADSSPSKSNH	ALPK2	156	Q86TB3
SGTGHANPTFKLQTP	ADAM19	756	Q9H013
GTPKTHSVPSATSKG	AFTPH	616	Q6ULP2
QSPPHGEAKAGSSTL	ARFGEF1	51	Q9Y6D6
HLTGNAPDSTTPGKK	ARFGEF1	111	Q9Y6D6
SSGPSPGAKFSHILQ	ARFGEF1	406	Q9Y6D6
KPPHGAAENSLSPSS	CD2	336	P06729
LASTPNDKASSPGHP	FAM117A	296	Q9C073
QPPATGHKRSTSEGA	GSDMD	241	P57764
PKGSLQAHDTSSLPT	AKAP13	1846	Q12802
SSLGDSAPERKSPSH	ARHGEF11	16	O15085
GGLPTESPHSSVKAS	ADGRL2	1106	O95490
GSPLHKQSSGPSSSP	CLIP2	41	Q9UDT6
HGPNTDLLGTSPKAS	ARFGAP2	191	Q8N6H7
ALGHSSGKPPADRTS	ARHGEF26	776	Q96DR7
SQKSHSPGTPGPRSS	AHI1-DT	21	P0C7V0
TSNGRHSASSPKAPD	RAD54L2	1146	Q9Y4B4
SSSPSGSPLHGKLNS	BCAS3	486	Q9H6U6
PRSPSHSGNAGDLKQ	BICC1	631	Q9H694
GPGGNSSSSSSLHKP	DLX2	36	Q07687
EHAPSPSSGGTLKND	CDK13	521	Q14004
NSPGLQTKEPSSSLH	CIT	1431	O14578
ESSPSNGHGKLAGPS	EEPD1	371	Q7L9B9
PPAATHSLGLGSNLS	FAM90A10	271	A6NDY2
PGTSAAKKATPGAHT	ARMCX2	251	Q7L311
PGAHTGAIPKATSAT	ARMCX2	261	Q7L311
AGSSGSLSRTHPPLQ	ARPP21	416	Q9UBL0
SLQTSLSSPLSGPHK	ATXN7L1	661	Q9ULK2
PGKPQAVSSLNSSHS	AFF4	181	Q9UHB7
SALGPKASPAPSHNS	CNOT3	351	O75175
PGEQDSLHTTPKQGS	MTUS2	386	Q5JR59
SLHTTPKQGSASLGG	MTUS2	391	Q5JR59
KPGKIDHLSSSAPGS	RC3H1	521	Q5TC82
SPHGFSGQSKPDLTA	RBM20	321	Q5T481
DQHSPIPLSTGLGST	QRICH2	891	Q9H0J4
SLGPGKTTAEPQHQS	FMN1	606	Q68DA7
GPSISPSHSQRIAGS	ITGAX	561	P20702
PPAATHSLGLGSNLS	FAM90A7	271	A6NKC0
TASTEGLPAKPGSHT	CDC42BPG	866	Q6DT37
KLDSPAGTALSPSGH	PYCR1	291	P32322
ENRTSPSKSPFLHSG	ARID1A	1596	O14497
PPAATHSLGLGSNLS	FAM90A23	271	A8MXZ1
GPQTSTSPASPKGLH	MUC16	10451	Q8WXI7
TSPASPKGLHTGGTK	MUC16	10456	Q8WXI7
HSEGGKRSPEPNKTS	NCOR2	2196	Q9Y618
TQPSASHPGGQSLKL	PARD3B	151	Q8TEW8
TGGHTSSTSPQLSKP	TCTE1	26	Q5JU00
SVISVSKGSPDGSHP	KLF4	246	O43474
PSTPSSGATVDSGKH	MICAL3	1761	Q7RTP6
NHSLGTGKPATQTGP	KMT2C	3001	Q8NEZ4
QKLSHSTKPSGSPLE	MATN2	896	O00339
KPASSAEINHSFTPG	KIAA1671	1261	Q9BY89
SLQSPSSAGGHPKAH	HOXA3	51	O43365
KLSSSSHPGSEAPES	NLRP8	671	Q86W28
PPAATHSLGLGSNLS	FAM90A1	271	Q86YD7
SALRNTGHEGKASPP	IRGM	51	A1A4Y4
QESPVTKSGHNSLPT	KIAA1109	2366	Q2LD37
TKSGHNSLPTGVAPN	KIAA1109	2371	Q2LD37
SPSHGDSKSPGLLSS	KDM6A	761	O15550
ASKGSHAEGLQSPAP	MTNR1B	336	P49286
PTSPSIRKQSGASGH	GJD4	231	Q96KN9
GGQTQSPTKSHTPSP	CAP2	296	P40123
PPAATHSLGLGSNLS	FAM90A22	271	A8MWA6
SLPTPAKSSSQGDHG	NHSL1	1141	Q5SYE7
PPAATHSLGLGSNLS	FAM90A14	271	P0C7W9
ESAGKATPDPGTHSK	GPATCH1	396	Q9BRR8
GKPDLQSQDHTSTGP	PCNX2	636	A6NKB5
GHISQKDPNGTSSLP	PIK3C2A	351	O00443
GTKQRSHGSPAPSTS	PDE1C	631	Q14123
PSPKHTPNTSDNEGS	PDZD8	966	Q8NEN9
KAHSRSSSGETPAQP	NLRP1	31	Q9C000
SPASQGDLHTKPLGT	NLRP1	1061	Q9C000
SNPTIGGLPVSHSKA	CSNKA2IP	286	A0A1B0GTH6
SSESPSGPKLGNSHI	EYA1	16	Q99502
LNSIHSSPGPKRSTN	KALRN	1751	O60229
GAGLQPLASPSHITT	EP400P1	236	Q6ZTU2
HGNPPPLTGTSKTSN	KREMEN1	126	Q96MU8
KSHNGAETTSLPPKT	KNL1	1651	Q8NG31
SPPGHTSQSALSLGA	TUBGCP6	1296	Q96RT7
PPAATHSLGLGSNLS	FAM90A17	271	P0DV74
SPGKSPSANGLSQKH	PTPRZ1	1501	P23471
PPAATHSLGLGSNLS	FAM90A16	271	P0DV73
SSSHQQSGLPPAKEG	RBM5	511	P52756
KSNSVSLVPPGSSHT	RICTOR	1281	Q6R327
PPAATHSLGLGSNLS	FAM90A19	271	P0DV76
AGTAKDSLSPVLHPS	GPN1	306	Q9HCN4
HQSDAGKQGLGPPST	MYOCD	216	Q8IZQ8
PIKHTVENGTGPSSA	SLC24A3	376	Q9HC58
QGSASPSKVEGVHTP	PACS1	491	Q6VY07
PKATSSHQGLGSTLP	NUTM1	961	Q86Y26
FDSSGSPAKPHTTLQ	PALB2	776	Q86YC2
PPAATHSLGLGSNLS	FAM90A8	271	A6NJQ4
SPDATGLSPKASLLH	C6orf15	156	Q6UXA7
LTPASSPVSSPSKHG	FZR1	31	Q9UM11
NHAASALPTGSPKRG	FBF1	501	Q8TES7
FHSEGSLQKGTEPSP	BCL7C	101	Q8WUZ0
SQCSPGPEGHRKTSS	BICRAL	931	Q6AI39
SKAPSSGSAQPPEGH	CABIN1	2101	Q9Y6J0
PEPGTATGSGIKSHN	DOK1	431	Q99704
TLNGAHSTSEGPAKP	FRMPD3	1226	Q5JV73
HSTSEGPAKPKSSRG	FRMPD3	1231	Q5JV73
GRGTKPEASSHQGTP	GALNT5	146	Q7Z7M9
LGSAAASPVHLKSPS	BCL9	911	O00512
HPAVSASQKGPEKGT	CACNA1I	1966	Q9P0X4
LTLSSPHGNANGDKP	DNAJC6	461	O75061
GSSHGTPTHQSKPQT	DNAJC6	661	O75061
HGSPGSSPKVLSQPS	GLI4	41	P10075
HSSSISPQDKLALPG	ASAP1	741	Q9ULH1
SGSPEHLQKPRSEGS	CCDC85A	231	Q96PX6
TEQPTLGHLDSKPSS	MARK2	16	Q7KZI7
GHGASLPSKKTPSEE	MAST2	496	Q6P0Q8
PTSAPTTSHNVGSKA	LYPD8	206	Q6UX82
SHASGREPGAKPSTA	MAST4	2156	O15021
TSTPTGHGASPAKQD	DAGLA	1021	Q9Y4D2
QGAGSPRSSPSHTIS	DTNA	556	Q9Y4J8
GKDSPTGTLSSPKHL	IL22RA1	411	Q8N6P7
VKQSSGEKHLPSSSP	KIAA1210	1356	Q9ULL0
SLEAHAGSPSLKTPD	KNDC1	716	Q76NI1
PGLSSQHPKPDTTVS	EMILIN2	226	Q9BXX0
PPSSSSHAGALQESL	FAF1	176	Q9UNN5
LFGSSTLSPHPTKGG	DHX34	1026	Q14147
PPAATHSLGLGSNLS	FAM90A5P	271	A8MXJ8
SGLKTPAPATTTSHN	RPRD2	491	Q5VT52
GALHTSSKPTALPSA	SASS6	631	Q6UVJ0
SGAVLSHQPTSPGSK	SALL4	116	Q9UJQ4
TSPSGLHSKLANGLP	POLR3E	521	Q9NVU0
SPTPGGTAHQALKAN	CEP131	381	Q9UPN4
PPAATHSLGLGSNLS	FAM90A24P	271	P0C7X0
DTEGKSPSHSSSNRP	MED1	1016	Q15648
HKPSPSRLSTGASAD	PRIMPOL	496	Q96LW4
STASLTKPHSTGPGS	PCARE	896	A6NGG8
SHSPTENSKGQSPPS	MINK1	916	Q8N4C8
QSPSGTLPALRTSHG	MTX1	196	Q13505
HGEGSLASSQAKAPP	NUTM2A	306	Q8IVF1
HGESSLASSQAKAPP	NUTM2B	306	A6NNL0
HGESSLASSQAKAPP	NUTM2E	306	B1AL46
PDSSAPSSPKLQHGS	NAV1	1246	Q8NEY1
PSSPKLQHGSTETAS	NAV1	1251	Q8NEY1
GAFTHGTQTPSPTKA	HHLA1	391	C9JL84
LSPGSSGLSNSHTPV	TRIM33	726	Q9UPN9
ESPAAPSSAGHTKGQ	TEX55	16	Q96M34
PKTPDGGHSSQEIKS	RAP1GAP2	591	Q684P5
GHASSSLPKSHLEPS	TATDN2	476	Q93075
DIKGSSQPASHKGSP	PRUNE2	2176	Q8WUY3
RGIPSSNDHGSLKAP	SPATA31C2	746	B4DYI2
GSFSSQHGSPSKLPL	NCKAP5	1356	O14513
LEKSTGHTPTKPSGS	NCOA7	351	Q8NI08
GHTPTKPSGSSVSEK	NCOA7	356	Q8NI08
RSESGSPSAGGHSKP	MYC	276	P01106
PPAATHSLGLGSNLS	FAM90A12P	271	A8MX19
PGVLTNHLGTSASSP	PRDM16	1041	Q9HAZ2
PPAATHSLGLGSNLS	FAM90A9	271	A6NNJ1
PPAATHSLGLGSNLS	FAM90A13P	271	P0C7W8
PGSSSQQGKPGLSSH	MARCOL	231	A0A1B0GUY1
SGASVPPHQSSPLGK	NCAN	911	O14594
PPAATHSLGLGSNLS	FAM90A26	271	D6RGX4
ESSSTLPLGGFQTHP	MRAP	126	Q8TCY5
LPSSPKLPHNGSTGS	NAV2	1866	Q8IVL1
KSSQETPAHSSGQPP	SMARCAL1	171	Q9NZC9
QTLPKSTRHPSGGSS	PLEKHA7	471	Q6IQ23
SGSKSPQLATPGSSH	SETD5	861	Q9C0A6
SIPGTLESGHPSNLT	SIGLEC6	151	O43699
SIKASKSLDGHSPSP	SNCAIP	736	Q9Y6H5
SGAPSPSPQKHGSLV	TAOK2	821	Q9UL54
AHSVPLDKASTSLPG	SPATA31E1	466	Q6ZUB1
GASSPRSSSPHDKNL	MYCBP2	2836	O75592
SGVKQGSGPAPTTHK	SPAST	276	Q9UBP0
LSHAPSPSPSASKVG	PRR12	806	Q9ULL5
PRGIPSSNDHGSLKA	SPATA31C1	751	P0DKV0
GAGKPHSSTSSPSVP	SPTY2D1	311	Q68D10
PPAATHSLGLGSNLS	FAM90A15P	271	P0C7V4
SSQEPSSGPLKLSAH	SPTBN5	1971	Q9NRC6
SSKSPHIGNSFLPDN	MLLT10	811	P55197
DSAPTLHLNKGTPSQ	AGFG1	166	P52594
KRTSGNQSHVDPGPT	CLN3	66	Q13286
APLIKSHSFPESSGQ	XIRP2	2341	A4UGR9
SHASSGPPRAALGKS	PITPNM1	1176	O00562
STHPSLSQRPGGSTK	TGOLN2	41	O43493
SHPELQTPKDSTGKS	TGOLN2	126	O43493
RASPKGSLSSAQPHS	SHF	31	Q7M4L6
HLNGTGPLKDTPSSS	USP42	466	Q9H9J4
SPSQGTLSAHPLGLS	USP43	361	Q70EL4
ASGHNGETKTPRPSS	TSC1	1011	Q92574
SLKDSSSPGHDSPLD	TICRR	1156	Q7Z2Z1
ISKDLNSPGPHSTNS	ZSCAN20	856	P17040
QVPSSPASKHSLGSD	RGS12	846	O14924
PHSPSKTDGKELAGT	PBXIP1	41	Q96AQ6
GSPKAALHSPVSEGA	SPHK2	476	Q9NRA0
PNHTGPGSEIATSEK	SSH2	1021	Q76I76
SPSLPQGSLFHSGTA	RIPOR3	476	Q96MK2
GDTRSPDAKSTGTPH	RP1L1	2321	Q8IWN7
QDPGLLVPKGHSSSD	SP7	106	Q8TDD2
GASSHKPGSSPSSPR	SYBU	186	Q9NX95
LSDSPAGSKDHGSVP	SOBP	111	A7XYQ1
APSSSPKHGLTSGSA	ZNF592	676	Q92610
VSGLHNKVATTPGSP	TNS1	1256	Q9HBL0
IGSPGNHKSPSSALS	FGD6	1291	Q6ZV73
TSPQKSSALAPEDHG	ZNF585B	6	Q52M93
ALGSSRSSPPKAAGH	nan	231	A8MX80
STSGSSDLPKAPGGH	RPS6KL1	311	Q9Y6S9
NGGAKETSHASLPQP	TCF20	641	Q9UGU0
SAPLSLSSDPGKVNH	PLCB1	1181	Q9NQ66
LSSDPGKVNHKTPSS	PLCB1	1186	Q9NQ66
ASSPHQAGLGLSLTP	SEC16B	946	Q96JE7
TSPQKSSALAPEDHG	ZNF585A	6	Q6P3V2
HSHDGPSLKETTGPS	SLC30A7	216	Q8NEW0
KPSGSLANTAPHGSS	ZNF469	1251	Q96JG9
NHSSPKPTTLNTAGA	ZBTB24	131	O43167
GKTPAQSTHSEAPPS	YY1AP1	476	Q9H869
GKDSGTSFNAVPLHP	ZG16	121	O60844
PKGAAVNGPVSHSSL	ZNF644	111	Q9H582
ASQRSPSKHGGPSAP	ZSWIM8	1036	A7E2V4
ASSLQSSAPKQGPLH	TTC7B	676	Q86TV6
GESDKGPHTSPSHTL	SH2D3C	461	Q8N5H7
PSHTLGKASPSPSLS	SH2D3C	471	Q8N5H7
HSSASSGVPNPPKAR	GTF3C2	771	Q8WUA4
ASPTQPSGTEKGGHV	TBX1	326	O43435
TPPGDSSSLPSHNGL	TXLNB	16	Q8N3L3
PHSSPAHNKLATATG	WDR11	206	Q9BZH6
PTESSSHGEGQNPKT	ZNF629	821	Q9UEG4
SEPSLNLLSPHSKGS	HIVEP2	381	P31629
LSSPSKHSDPTLPGT	RIPOR1	691	Q6ZS17
RPHNIKDSFSGPSTS	TIGD7	531	Q6NT04
PSTHIPPLDSKGANS	PPP1R1A	156	Q13522
KALVHSSSPSPALNG	SOCS6	156	O14544
STAGHSKTPPSGADS	USP36	646	Q9P275
DLGKDPNGPTHSSTL	TERF2IP	6	Q9NYB0
SQGTGSPVPKIHGSS	YEATS2	531	Q9ULM3
KLNPGAHELSPGQSS	ZIC2	61	O95409
GKNAASSPSVPSHPS	UNC79	1661	Q9P2D8
PPAATHSLGLGSNLS	FAM90A18	271	P0DV75
SLPHEGSSPSLAGSQ	KMT2D	3296	O14686
HSKPGSTETTLSPGS	MUC12	4941	Q9UKN1
SHPSVQTKSPGGLSI	MYPN	766	Q86TC9
PVKSHFGSNPIGSAT	MYT1	136	Q01538
SSPGVKSPDASQRHS	MYT1	691	Q01538
LTTPPGHGTLDNSKS	NEUROD6	216	Q96NK8